好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2010 Annual Meeting | Poster Session 06

Thursday 04/15/10
03:00 PM - 07:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Cerebrovascular Disease and Interventional Neurology, Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Aging and Dementia, Headache, MS and Related Diseases, Muscle Disease/Neuromuscular Junction, Neuroepidemiology/Health Services and Outcomes Research, Neurogenetics and Gene Therapy, Neurologic 好色先生, Neurotoxicology, Peripheral Nerve
No CME available
Event Timeline
03:00 PM - 04:30 AM Break
03:00 PM - 07:30 PM Abstract 001 - Acute Kidney Injury Is Associated with Hospital Mortality after Acute Ischemic Stroke, but Not Intracerebral Hemorrhage
03:00 PM - 07:30 PM Abstract 002 - Depressive Symptoms and Incidence of First Stroke: Does Stroke Risk Decline after Depressive Symptoms Resolve?
03:00 PM - 07:30 PM Abstract 003 - Incidence of Cerebral Venous Thrombosis in United States: 2002-2006. A National Analysis
03:00 PM - 07:30 PM Abstract 004 - Endocarditis Is a Common Stroke Mechanism in Hemodialysis Patients
03:00 PM - 07:30 PM Abstract 005 - Low Rates of Blood Pressure Goal Achievement among Minorities with Stroke and Coronary Artery Disease Are Not Due to Less Aggressive Treatment
03:00 PM - 07:30 PM Abstract 006 - Physical Activity and Functional Outcome from Stroke
03:00 PM - 07:30 PM Abstract 007 - Should ICH Outcome Prediction Models Be Modified in African Americans?
03:00 PM - 07:30 PM Abstract 008 - Load of Myocardial Infarction and Risk of Brain Infarction: The AGES-Reykjavik Study
03:00 PM - 07:30 PM Abstract 009 - The Northern Manhattan Study Global Vascular Risk Score Is Associated with Leukoaraiosis
03:00 PM - 07:30 PM Abstract 010 - Newly Diagnosed Diabetes Portends a Poor Outcome for Acute Stroke Patients Regardless of the Subtype
03:00 PM - 07:30 PM Abstract 011 - Chocolate Consumption and Risk of Stroke
03:00 PM - 07:30 PM Abstract 012 - Seasonal Variation of Stroke in Relation to Influenza Infection
03:00 PM - 07:30 PM Abstract 013 - Trends in Outcome and Hospitalization Cost among Adult Patients with Acute Ischemic Stroke in the United States
03:00 PM - 07:30 PM Abstract 014 - Accuracy of the New ICD-9 Code for "Drip-and-Ship" Thrombolytic Treatment in Patients with Acute Ischemic Stroke
03:00 PM - 07:30 PM Abstract 015 - Racial and Geographic Differences in Fish Consumption: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study
03:00 PM - 07:30 PM Abstract 016 - Stroke-Associated Pneumonia (SAP): Do Academic and Community Hospitals Have Similar Incident Risk and Outcomes?
03:00 PM - 07:30 PM Abstract 017 - Prevalence of Thyroid Abnormalities and Associations with Cerebrovascular Disease in a Nationwide Survey
03:00 PM - 07:30 PM Abstract 018 - Pronounced Association of Elevated Serum Homocysteine with Stroke in Subgroups of Individuals: A Nationwide Study
03:00 PM - 07:30 PM Abstract 019 - Impact of Microalbuminuria on Incident Stroke Risk: A Meta-Analysis
03:00 PM - 07:30 PM Abstract 020 - Incidence of First Stroke in a Total Population Study
03:00 PM - 07:30 PM Abstract 021 - Distal Myopathies: A Retrospective Study of 28 Cases
03:00 PM - 07:30 PM Abstract 022 - Progressive Dysphagia in Limb Girdle Muscular Dystrophy Type 2B: An Extension of the Clinical Phenotype
03:00 PM - 07:30 PM Abstract 023 - Oculopharyngodistal Myopathy Is a Distinct Entity - Clinical and Genetic Characterization of 40 Turkish OPDM Patients
03:00 PM - 07:30 PM Abstract 024 - Dominant Cardiomyopathy and Very Distal Myopathy with Rod, Myofibrillar and AVSF Myopathology
03:00 PM - 07:30 PM Abstract 025 - Hereditary Myopathy with Early Respiratory Failure (HMERF) - A Uniform Clinical Phenotype with Several Possible Genotypes
03:00 PM - 07:30 PM Abstract 026 - Non-GNE Related Quadriceps Sparing Myopathy: A Case Report
03:00 PM - 07:30 PM Abstract 027 - Scoliosis Surgery (ScSu) in Respiratorily-Compromised Congenital Neuromuscular Patients Can Fatally Worsen Ventilatory Function or Engender Nocturnal BiPAP Dependency, as Evidenced in Four Children with Focal-Loss-of-Cross-Striations (FLCS)
03:00 PM - 07:30 PM Abstract 028 - Sparing of Myofiber Membranes in Infantile Pompe's Disease: Dissociated Excitation-Contraction Coupling
03:00 PM - 07:30 PM Abstract 029 - Clinical Methodology and Outcome of Enzyme Replacement Therapy in a Series of Late-Onset GSDII Patients
03:00 PM - 07:30 PM Abstract 030 - Analysis of Cardiac Involvement in Children and Adults with Pompe Disease from the Pompe Registry
03:00 PM - 07:30 PM Abstract 031 - Enzyme Replacement Therapy in Five Adults with Late-Onset Pompe Disease
03:00 PM - 07:30 PM Abstract 032 - Characterization of Non-Length-Dependent Small Fiber Sensory Neuropathy
03:00 PM - 07:30 PM Abstract 033 - Natural History of Idiopathic Small and Large Fiber Polyneuropathy: A Retrospective Study
03:00 PM - 07:30 PM Abstract 034 - Sensory Neuropathy in Patients with Cryoglobulin Negative Hepatitis-C Infection
03:00 PM - 07:30 PM Abstract 036 - Peripheral and Central Large Fiber Dysfunction in Idiopathic Hyperhomocysteinemia
03:00 PM - 07:30 PM Abstract 037 - Lower Extremity Weakness and Dysesthesias Associated with Zinc Deficiency
03:00 PM - 07:30 PM Abstract 038 - The Pathological Characterization of Peripheral Neuropathy in Copper Deficiency
03:00 PM - 07:30 PM Abstract 039 - Statin Toxicity for Sensory Neurons In Vitro: Mechanism of Action Distinct from Cholesterol Synthesis
03:00 PM - 07:30 PM Abstract 040 - Sensori-Motor CMT "Like" Neuropathy with Ataxia Ophtalmoplegia and Dysarthria in Moroccan Patient with Homozygote POLG Mutation
03:00 PM - 07:30 PM Abstract 041 - SCA3 Presenting as an Isolated Axonal Polyneuropathy
03:00 PM - 07:30 PM Abstract 042 - Impaired Neurovascular Repair in Subjects with Diabetes Following Intracutaneous Axotomy
03:00 PM - 07:30 PM Abstract 043 - MNSI, Electrophysiologic and Epidermal Nerve Fiber Density Findings in Cryptogenic Sensory Polyneuropathy Compared to Diabetic Polyneuropathy and Normal Controls
03:00 PM - 07:30 PM Abstract 044 - Is Clinically Diagnosed Diabetic Peripheral Neuropathy Predominantly Metabolic or Vascular in Origin?
03:00 PM - 07:30 PM Abstract 045 - Electrodiagnostic Features of CIDP in Diabetes Mellitus
03:00 PM - 07:30 PM Abstract 046 - Type 2 Diabetes Mellitus Exacerbates Neuropathy in Patients with CMT1a
03:00 PM - 07:30 PM Abstract 047 - Epidemiology of Peripheral Neuropathy (PN) in a Tertiary Neuromuscular Disease Clinic in Northeast Brazil
03:00 PM - 07:30 PM Abstract 048 - Multi-Factorial Analysis of Risk Factors for the Development of Peripheral Neuropathy
03:00 PM - 07:30 PM Abstract 049 - Dizziness and Loss of Balance in Diabetics: The Relative Contribution of Vestibular vs. Somatosensory Dysfunction; Implications for Therapeutic Intervention
03:00 PM - 07:30 PM Abstract 050 - Effects of Brief Supervised Exercise Program on Diabetic Neuropathy
03:00 PM - 07:30 PM Abstract 051 - Timed Vibration Predicts Progression to Symptomatic Neuropathy in Diabetic Subjects
03:00 PM - 07:30 PM Abstract 052 - Acute Motor Axonal Neuropathy Presenting with Ventral Horn and Proximal Root Involvement: A Case Report and Review of the Literature
03:00 PM - 07:30 PM Abstract 053 - Guillain-Barre Syndrome after Influenza Vaccination in the United States. A Report from the CDC/FDA Vaccine Adverse Event Reporting System. (1990-2009)
03:00 PM - 07:30 PM Abstract 055 - Guillain-Barre Syndrome after Hepatitis Vaccination in the United States. A Report from the CDC/FDA Vaccine Adverse Event Reporting System. (1990-2009)
03:00 PM - 07:30 PM Abstract 056 - Guillain-Barre Syndrome after GARDASIL Vaccination in the United States. A Report from the CDC/FDA Vaccine Adverse Event Reporting System. (2006-2009)
03:00 PM - 07:30 PM Abstract 057 - Acute Motor Conduction Block Neuropathy (AMCBN): Review of Eleven Cases
03:00 PM - 07:30 PM Abstract 058 - Anti-Ganglioside Antibodies in Guillain-Barr[eacute] Syndrome Patient Sera Activate Small GTPase RhoA
03:00 PM - 07:30 PM Abstract 059 - Preciding Infections, the Spectrum of Morbidity and Outcome of Guillain-Barr[eacute] Syndrome in the Intensive Care Unit
03:00 PM - 07:30 PM Abstract 060 - Case of Recurrent Guillain-Barr[eacute] Syndrome with Three Episodes
03:00 PM - 07:30 PM Abstract 061 - Rituximab in Polyneuropathies with Anti-MAG Antibodies: Efficacy, Tolerance and Predictive Factors of Response to Treatment
03:00 PM - 07:30 PM Abstract 062 - Cauda Equina Hypertrophy with Abundant Onion Bulb Formation Presenting as a Lower Motor Neuron Syndrome
03:00 PM - 07:30 PM Abstract 063 - Chronic Inflammatory Demyelinating Polyneuropathy Disease Activity Status (CDAS): Recommendations for Clinical Research Standards
03:00 PM - 07:30 PM Abstract 064 - A Randomized Controlled Trial Comparing Two Different IV Immunoglobulins in CIDP (CIC-Study)
03:00 PM - 07:30 PM Abstract 065 - Real World Use of IVIg in CIDP: Assessment of Utilization across the Scope of Practice
03:00 PM - 07:30 PM Abstract 066 - Proteonomic Analysis of Amyloid-Like IgM Neuropathy in Waldenstrom's Macroglobulinemia
03:00 PM - 07:30 PM Abstract 067 - Increased Frequency of HLA-DRB1*15 in Patients with Multifocal Motor Neuropathy
03:00 PM - 07:30 PM Abstract 068 - Autonomic Dysfunction in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
03:00 PM - 07:30 PM Abstract 069 - Non-Myeloblative Autologous Hematopoietic Stem Cell Transplantation for Chronic Inflammatory Demyelinating Neuropathy (CIDP) Treatment
03:00 PM - 07:30 PM Abstract 070 - Interest of Intensive Intravenous Immunoglobulins (IVIG) Regimen in CIDP Partially IVIg Responders
03:00 PM - 07:30 PM Abstract 071 - Clinical Characteristics and Potential Therapeutic Implications of Inflammatory Pseudotumor of Nerve
03:00 PM - 07:30 PM Abstract 072 - Inflammatory Post-Surgical Neuropathy
03:00 PM - 07:30 PM Abstract 073 - Anterior Interosseous Nerve Syndrome Following Procedures
03:00 PM - 07:30 PM Abstract 074 - Phrenic Nerve Pacemaker for Isolated Diaphragmatic Palsy in Neuralgic Amyotrophy
03:00 PM - 07:30 PM Abstract 075 - Phrenic Neuropathies: A Clinical and Electrodiagnostic Study
03:00 PM - 07:30 PM Abstract 076 - The Timing and Distribution of Triggers among 268 Bouts of Neuralgic Amyotrophy
03:00 PM - 07:30 PM Abstract 077 - Hold Your Arms High Traction Lesions of the Brachial Plexus in Bodyflying
03:00 PM - 07:30 PM Abstract 078 - High-Dose Intravenous Steroids in Definite or Suspected Immune-Mediated Neuropathies
03:00 PM - 07:30 PM Abstract 079 - Predictors of Positive Nerve Biopsies in Presumed Vasculitis
03:00 PM - 07:30 PM Abstract 080 - Hereditary Neuropathy with Pressure Palsies: Analysis of 24 De Novo Unrelated Cases
03:00 PM - 07:30 PM Abstract 081 - Disparities in the Diagnosis of Duchenne and Becker Muscular Dystrophy: Data from the MDSTARnet, 1999-2007
03:00 PM - 07:30 PM Abstract 082 - Respiratory Care Trends for Duchenne and Becker Muscular Dystrophies (DBMD): Data from the MD STARnet, 2001-2007
03:00 PM - 07:30 PM Abstract 083 - Clinical and Electrophysiological Features in Fifty-Eight Chilean Children with Guillain-Barr[eacute] Syndrome
03:00 PM - 07:30 PM Abstract 084 - Impact of Botulinum Toxin Type A (BoNTA) on Health Utility in Patients Receiving Treatment for Approved Therapeutic Indications: Interim Analysis of a Large Ongoing Phase IV Prospective Observational Cohort Study (MDs on BOTOX[reg] Utility-Mobility) in Canada
03:00 PM - 07:30 PM Abstract 085 - Evaluation of Quality of Life in Korean Charcot-Marie-Tooth Disease Patients
03:00 PM - 07:30 PM Abstract 086 - Caregiving Parents of Children with Neuromuscular Conditions: Experiences of Stress and Personal Growth
03:00 PM - 07:30 PM Abstract 087 - Baseline Characteristics of Patients Receiving Botulinum Toxin Type A for Approved Therapeutic Indications in a Large Ongoing Phase IV Prospective Observational Cohort Study (MDs on BOTOX[reg] UTILITY - MOBILITY) in Canada
03:00 PM - 07:30 PM Abstract 088 - Edge Motion Technology To Detect Abnormalities of Gait and Balance
03:00 PM - 07:30 PM Abstract 089 - Dual-Task Related Gait Changes and Risk of Falls: A Systematic Review
03:00 PM - 07:30 PM Abstract 090 - Incidence of Central Nervous System Tumors in Two Different Populations from Argentina
03:00 PM - 07:30 PM Abstract 091 - Pattern of Pediatric Brain Tumors in Province of Egypt, a Multidisciplinary Team Experience
03:00 PM - 07:30 PM Abstract 092 - Hemangiopericytoma Affecting the Central Nervous System
03:00 PM - 07:30 PM Abstract 093 - Esthesioneuroblastoma: Clinical and Survival Analysis at a Single Institution in Argentina
03:00 PM - 07:30 PM Abstract 094 - Glioblastoma Multiforme, Adenoid-Type with Melanocytic Differentiation
03:00 PM - 07:30 PM Abstract 095 - Brain Metastases from Melanoma: Implications for Future Studies
03:00 PM - 07:30 PM Abstract 096 - A Retrospective Study of Central Nervous System Metastases in Esophageal Cancer
03:00 PM - 07:30 PM Abstract 097 - Incidence of Cerebral Metastasis: A Population Based Study in an Island Community
03:00 PM - 07:30 PM Abstract 098 - Upfront Association of Carboplatin and Pemetrexed in Patients with Brain Metastasis of a Non Small Cell Lung Cancer
03:00 PM - 07:30 PM Abstract 099 - Bevacizumab as Treatment for Brain Metastasis of Lung Cancer
03:00 PM - 07:30 PM Abstract 100 - Leptomeningeal Plasmacytosis as an Early Manifestation of Waldenstrom's Macroglobulinemia - A Case Report
03:00 PM - 07:30 PM Abstract 101 - Richter's Syndrome of the Spinal Cord
03:00 PM - 07:30 PM Abstract 102 - Cranial Nerve Neuropathy as Initial Presentation of Recurrent Multiple Myeloma
03:00 PM - 07:30 PM Abstract 103 - A Unique Case of Hyperviscosity Syndrome in a Patient with Chronic Lymphocytic Leukemia Treated with Rituximab
03:00 PM - 07:30 PM Abstract 104 - Acute Obstructive Hydrocephallus in Griscelli Syndrome
03:00 PM - 07:30 PM Abstract 105 - A Case of Intracranial Plasma Cell Granuloma Presenting as a Mass Lesion
03:00 PM - 07:30 PM Abstract 106 - Subdural Hematoma in Cancer Patients
03:00 PM - 07:30 PM Abstract 107 - Orofacial Dyskinesia: A Possible Paraneoplasic Disoder?
03:00 PM - 07:30 PM Abstract 108 - Previous Biopsy History and Histopathological Outcome Affect Cognition and Quality of Life Following Breast Biopsy
03:00 PM - 07:30 PM Abstract 109 - Coagulation State and Carotid Profile Assessment as a Cerebrovascular Complication in Central Nervous System Tumor
03:00 PM - 07:30 PM Abstract 110 - Gemcitabine Induced Myopathy
03:00 PM - 07:30 PM Abstract 111 - Voltage Gated Potassium Channel Antibody Negative Neuromyotonia and Optic Neuritis Associated with Hodgkin Lymphoma: Paraneoplastic Neuromyotonia Plus
03:00 PM - 07:30 PM Abstract 112 - A Case of Mistaken Identity: Anti-NMDA Receptor Encephalitis in a Young Woman
03:00 PM - 07:30 PM Abstract 113 - Steroid Responsive Encephalopathy Associated with Vestibular Symptoms and Sleep Disorders: Clinical, PSG, MSLT, ENG, CSF, and Brain MRI Correlates
03:00 PM - 07:30 PM Abstract 114 - Brain and Spinal Cord Infarction Secondary to Giant Cell Arteritis (GCA) after Intrathecal Ziconotide
03:00 PM - 07:30 PM Abstract 115 - Rare Neurological Complications Associated with Intravenous Immunoglobulin Infusion
03:00 PM - 07:30 PM Abstract 116 - Striational Antibodies in a Paraneoplastic Context: A Case-Control Study
03:00 PM - 07:30 PM Abstract 117 - Cerebrotendinous Xanthomatosis: Clinical Manifestations in Long-Term Follow-Up
03:00 PM - 07:30 PM Abstract 118 - Cognitive Impairment in Moderate Chronic Kidney Disease Compared with Hemodialysis Patients: A Pilot Study
03:00 PM - 07:30 PM Abstract 119 - Summary of Cardiac Safety from a Randomized, Placebo-Controlled, Trial of Dextromethorphan/Quinidine (STAR) for Treatment of Pseudobulbar Affect
03:00 PM - 07:30 PM Abstract 120 - Cognitive Dysfunctions in Primary Sj[ouml]gren Syndrome
03:00 PM - 07:30 PM Abstract 121 - Auto-Immune Encephalitis: Cinical, Radiological and Immunological Data
03:00 PM - 07:30 PM Abstract 122 - Peripheral and Central Nervous System (PNS and CNS) Involvement in the Primary Carnitine Deficiency of Adult
03:00 PM - 07:30 PM Abstract 123 - Celiac Disease Presenting as a Disabling Myopathy without Gastronintenstinal Symptoms
03:00 PM - 07:30 PM Abstract 124 - Idiopathic Intracranial Hypertension Treatment Trial
03:00 PM - 07:30 PM Abstract 125 - Auto-Immune Encephalitis and Striatal Hypermetabolism
03:00 PM - 07:30 PM Abstract 126 - Hashimoto's Encephalopathy and Idiopathic Thrombocytopenic Purpura
03:00 PM - 07:30 PM Abstract 127 - Mononeuritis Multiplex as Result of Acute Hepatitis B-Related Vasculitis
03:00 PM - 07:30 PM Abstract 128 - Safety and Tolerability of Dextromethorphan/Quinidine for Pseudobulbar Affect in a 12-Week, Open-Label Extension Study
03:00 PM - 07:30 PM Abstract 129 - Proton Magnetic Resonance Spectroscopy (1)H-MRS as a Tool in Neuroimmunological Disease Monitoring
03:00 PM - 07:30 PM Abstract 130 - Hypoglycemic Encephalopathy with Normal Brain MRI
03:00 PM - 07:30 PM Abstract 131 - Efficacy and Safety of Weekly Intramuscular Interferon Beta-1a in Patients More Than 50 Years of Age
03:00 PM - 07:30 PM Abstract 132 - Nocebo Responses in Disease-Modifying and Symptomatic Treatment Trials for Multiple Sclerosis: A Systematic Review
03:00 PM - 07:30 PM Abstract 133 - Natalizumab Is Effective in RRMS Patients Who Do Not Respond to Sequential Therapy with Interferon beta and Glatiramer Acetate: Result of a Switching Study
03:00 PM - 07:30 PM Abstract 134 - Phase II Double-Blind Controlled Clinical Trial with T-Cell Vaccination in Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 135 - Cancer Risk among Patients with Multiple Sclerosis during the Treatment Era: The CARIMS Study Update
03:00 PM - 07:30 PM Abstract 136 - Response to Treatment with Sustained Release Fampridine in Patients with Multiple Sclerosis Is Independent of Baseline Patient Characteristics and Concomitant Immunomodulator Therapy
03:00 PM - 07:30 PM Abstract 137 - Oral Fingolimod (FTY720) Treatment Improves the Performance of Daily Activities Compared with Intramuscular Interferon [beta]-1a: Patient-Reported Indices for Multiple Sclerosis (PRIMUS)-Activities Results from a Phase III Study (TRANSFORMS)
03:00 PM - 07:30 PM Abstract 138 - Short-Term Immunosuppression with Mitoxantrone Followed by Long-Term Glatiramer Acetate vs Glatiramer Acetate Alone: Results at 60 Months in Patients with Relapsing Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 139 - Surgical Procedures for Medically Intractable Multiple Sclerosis Associated Trigeminal Neuralgia
03:00 PM - 07:30 PM Abstract 141 - Immunogenicity of PEGylated Interferon Beta-1a: Data from Preclinical and Phase 1 Clinical Studies
03:00 PM - 07:30 PM Abstract 142 - Evaluation of Natalizumab for the Relief of Multiple Sclerosis Associated Fatigue: The ENER-G Study
03:00 PM - 07:30 PM Abstract 143 - Immunotherapy after Discontinuation of Natalizumab in Relapsing Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 144 - Combined Transcranial and Extracranial Venous Doppler Evaluation (CTEVD Study). Description of the Design and Interim Results of an Epidemiological Study of the Prevalence of Chronic Cerebrospinal Venous Insufficiency in MS and Related Diseases
03:00 PM - 07:30 PM Abstract 145 - Adherence to Disease-Modifying Therapies in Patients with Relapsing Multiple Sclerosis: 2-Year Interim Results of the Global Adherence Project
03:00 PM - 07:30 PM Abstract 146 - Utilization and Safety of Intramuscular Interferon Beta-1a in the Postmarketing Setting
03:00 PM - 07:30 PM Abstract 148 - Objective and Subjective Efficacy of Natalizumab on Disability and Fatigue in Relapsing Remitting (RR) and Relapsing Progressive (RP) Multiple Sclerosis (MS) over a 2 Year Period
03:00 PM - 07:30 PM Abstract 149 - Baseline Characteristics of Patients in the DEFINE Trial: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Study of BG-12 in Relapsing-Remitting Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 150 - ReaLiNat Study: A European Multicenter Study Investigating Benefits and Risks of Natalizumab in Real Life
03:00 PM - 07:30 PM Abstract 151 - Discontinuing Disease Modifying Therapy in Progressive Multiple Sclerosis - Can We Stop What We Have Started?
03:00 PM - 07:30 PM Abstract 152 - Comparison of Adherence and Persistence Associated with First-Line Disease-Modifying Therapies among Patients with Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 153 - Factors Related to Adherence in Spanish Patients with MS: 2 Year Results of the GAP Study
03:00 PM - 07:30 PM Abstract 154 - Baseline Characteristics of a Subpopulation of Indian Patients Enrolled in Two Phase 3 Trials for Oral BG-12 in Relapsing-Remitting Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 155 - Clinical Efficacy of Natalizumab and Immunological Effects in Progressive MS Patients with High Degrees of Disability
03:00 PM - 07:30 PM Abstract 156 - Real-World Assessment of Adherence and Persistence to Second-Line Disease-Modifying Therapies among Multiple Sclerosis Patients
03:00 PM - 07:30 PM Abstract 157 - GERONIMUS Study: Progression Rates to Multiple Sclerosis According to McDonald and Poser Criteria in Patients with Clinically Isolated Syndrome. On Behalf of the GERONIMUS Study Group
03:00 PM - 07:30 PM Abstract 158 - Baseline Characteristics of Patients Enrolled in a Randomized, Multicenter, Placebo-Controlled and Active Comparator Trial Evaluating Efficacy and Safety of BG-12 in Relapsing-Remitting Multiple Sclerosis: The CONFIRM Trial
03:00 PM - 07:30 PM Abstract 159 - Efficacy of Short Courses of Parenteral Cladribine in Patients with Aggressive Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 160 - High Dose Cyclophosphamide Treatment in Marburg Variant of Multiple Sclerosis (MS): A Case Report
03:00 PM - 07:30 PM Abstract 161 - Impact of Intramuscular Interferon Beta-1a on Multiple Sclerosis Disease Severity: Analysis of Patients from the MSCRG and ASSURANCE Studies Using the Multiple Sclerosis Severity Scale
03:00 PM - 07:30 PM Abstract 162 - Characteristics of Switching from Interferon beta to Glatiramer Acetate in Non Respondent Relapsing Remitting Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 163 - Four Cases of Co-Morbid Multiple Sclerosis and Psoriasis: Sustained Remission of Both Conditions While on Natalizumab
03:00 PM - 07:30 PM Abstract 164 - Exploring Alemtuzumab's Long Term Efficacy and Safety: Design of the CARE-MS Extension Study
03:00 PM - 07:30 PM Abstract 165 - Efficacy of Natalizumab in a French Cohort of Multiple Sclerosis Patients
03:00 PM - 07:30 PM Abstract 166 - Central Demyelination Complicating the Use of Anti-TNF[alpha] in the Treatment of Inflammatory Bowel Disease(IBD): A Retrospective Study
03:00 PM - 07:30 PM Abstract 167 - Improvement in Patient-Reported Fatigue and Cognitive Function over Time with Natalizumab Treatment
03:00 PM - 07:30 PM Abstract 168 - Motherhood and Natalizumab - Effects of Natalizumab Therapy on Pregnancy Outcome and Disease Activity during Pregnancy
03:00 PM - 07:30 PM Abstract 169 - Dosing of Rituximab in Demyelinating Disease: How Much Is Enough?
03:00 PM - 07:30 PM Abstract 170 - Oral Fingolimod (FTY720) Reduces the Rate of Relapses That Require Steroid Intervention or Hospitalization Compared with Intramuscular Interferon [beta]-1a: Results from a Phase III Study (TRANSFORMS) in Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 171 - Oral Fingolimod (FTY720) vs Placebo in Relapsing-Remitting Multiple Sclerosis: 24-Month Safety and Tolerability Results from a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Study (FREEDOMS)
03:00 PM - 07:30 PM Abstract 172 - Leukocyte Dynamics Following Alemtuzumab Treatment of Relapsing-Remitting Multiple Sclerosis in a Phase 2 Study (CAMMS223)
03:00 PM - 07:30 PM Abstract 173 - Efficacy and Safety of Natalizumab in the STRATA Study
03:00 PM - 07:30 PM Abstract 174 - Simvastatin Treatment Favours the Long Term Outcome of Patients with ON
03:00 PM - 07:30 PM Abstract 175 - Efficacy of Natalizumab after Insufficient Response to Other Disease Modifying Therapies for the Treatment of Relapsing Remitting Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 176 - Natalizumab Treatment for Multiple Sclerosis in Clinical Practice
03:00 PM - 07:30 PM Abstract 178 - Immunological Response to Glatiramer Acetate in MS Patients after Different Pretreatments - The CopImmunoNet Study
03:00 PM - 07:30 PM Abstract 179 - Development and First Evaluation of the New Patient Management and Documentation System MSDS 3D for Patients with Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 180 - Intellectual Enrichment Lessens the Negative Impact of Brain Atrophy on Cognition in Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 181 - Multiple Sclerosis (MS) and Pregnancy: A Comparison Study
03:00 PM - 07:30 PM Abstract 182 - Inflammatory Cytokines and Chemokines in the Cerebrospinal Fluid of Multiple Sclerosis Patients Following Administration of Natalizumab
03:00 PM - 07:30 PM Abstract 183 - PI3K[gamma]: A Sex-Specific and Novel Therapeutic Target in the Treatment of CNS Autoimmune Injury
03:00 PM - 07:30 PM Abstract 184 - Anti-Inflammatory and Pro-Metabolic Effects of BG-12 in Glial Cells
03:00 PM - 07:30 PM Abstract 185 - On Prediction Power of MRI for Future Development of Relapse Remitting Form of Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 186 - Relapsing Tumefactive Lesions Are Associated with a More Aggressive Course of Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 187 - Diffusion Tensor Imaging as a Clinical Trial Outcome Metric: Sample Size Estimates
03:00 PM - 07:30 PM Abstract 188 - Memory Impairment in MS Correlates to Hemodynamic Response in Event-Related fMRI of Episodic Memory
03:00 PM - 07:30 PM Abstract 189 - Early MS Activity on Subtraction MRI Predicts Lesion Accrual and Atrophy over 5 Years
03:00 PM - 07:30 PM Abstract 190 - Diffusion Tensor Imaging Reveals Differences in Normal Appearing Corpus Callosum in Childhood Onset Multiple Sclerosis and Monophasic Demyelinating Events
03:00 PM - 07:30 PM Abstract 191 - White Holes and Their Impact on Physical Disability in Patients with Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 192 - MRI-Only Conversion to MS Following a Clinically Isolated Syndrome
03:00 PM - 07:30 PM Abstract 193 - Post-Natalizumab Rebound: A CNS Immune Reconstitution Inflammatory Syndrome (CIRIS)
03:00 PM - 07:30 PM Abstract 194 - Diagnosing Multiple Sclerosis from Conventional MR Images Using Pattern Recognition Techniques
03:00 PM - 07:30 PM Abstract 195 - Multiple Sclerosis and Systemic Sarcoidosis: A Double Diagnosis
03:00 PM - 07:30 PM Abstract 196 - Cerbral Amyloid Angiitis: Two Unique Case Presentations
03:00 PM - 07:30 PM Abstract 197 - An Unusual Case of a Rapidly Progressive Leucoencephalopathy
03:00 PM - 07:30 PM Abstract 198 - Development of Neurosarcoidosis during Exposure to Anti-TNF-Alpha Medications for Rheumatoid Arthritis: Case Report
03:00 PM - 07:30 PM Abstract 199 - Solitary Focal Demyelinating Lesion as a Cause of Progressive Myelopathy
03:00 PM - 07:30 PM Abstract 200 - Multiple Sclerosis in a Patient with Duchenne Muscular Dystrophy
03:00 PM - 07:30 PM Abstract 201 - Atypical Symptoms to 'Flag' Non-Demyelinating Disease in Patients with Suspected MS
03:00 PM - 07:30 PM Abstract 202 - Association of Parkinsonian Syndrom with Multiple Sclerosis: A Report of 27 Cases
03:00 PM - 07:30 PM Abstract 203 - Long-Term Intrathecal Baclofen Therapy in Ambulatory Multiple Sclerosis Patients
03:00 PM - 07:30 PM Abstract 204 - Therapeutic Considerations and Outcome of Steroid Refractory Neurosarcoidosis: 5-Years Single Centre Experience
03:00 PM - 07:30 PM Abstract 205 - Ingested (Oral) Somatostatin (SST) Inhibits Acute EAE
03:00 PM - 07:30 PM Abstract 206 - Possible Neuroprotection and Th17 Modulation by a Red Wine Component, Resveratrol, in a Mouse Model for Multiple Sclerosis, Theiler's Virus Infection
03:00 PM - 07:30 PM Abstract 207 - Detailed Analysis of CD52 Expression and Cellular Depletion/Repopulation after Alemtuzumab Treatment in HuCD52 Transgenic Mice
03:00 PM - 07:30 PM Abstract 208 - Axonal Protection Effect of Laquinimod Appears Partially Independent of Its Inhibitory Effect on Inflammation and Demyelination in Experimental Autoimmune Encephalomyelitis
03:00 PM - 07:30 PM Abstract 209 - Protection from CD8+ T Cell-Mediated Experimental Autoimmune Encephalomyelitis by CD28 Superagonist- or Glatiramer Acetate-Stimulated CD4+ T Cells
03:00 PM - 07:30 PM Abstract 210 - Intrathecal Methotrexate Reduces Astrogliosis in a Murine Model of Experimental Demyelination
03:00 PM - 07:30 PM Abstract 211 - Effects of Acamprosate (Acamp) in Experimental Autoimmune Encephalomyelitis (EAE)
03:00 PM - 07:30 PM Abstract 212 - Oral Treatment with Purified Polysaccharide A (PSA) of Human Commensal Bacteroides fragilis Protects Against Experimental CNS Demyelinating Disease
03:00 PM - 07:30 PM Abstract 213 - Therapeutic Effects of Oral Fingolimod (FTY720) in an Animal Model of the Progressive Disability of Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 214 - Effects of Glatiramer Acetate on T Cells in the Mouse Model
03:00 PM - 07:30 PM Abstract 215 - Beneficial Effect of IgG Glycans Hydrolysis by EndoS in Experimental Autoimmune Encephalitis
03:00 PM - 07:30 PM Abstract 216 - Alteration of Osteopontin Cytokine Expression in Experimental Autoimmune Encephalomyelitis by Glatiramer Acetate
03:00 PM - 07:30 PM Abstract 217 - Lipoic Acid Confers Neuroprotection in Experimental Autoimmune Optic Neuritis
03:00 PM - 07:30 PM Abstract 218 - A Cyclophilin D Inhibitor (Debio 025) Protects Axons in Experimental Autoimmune Encephlomyelitis: A New Therapeutic Target for Neuroprotecion in Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 219 - Dietary Supplementation with N-3 Polyunsaturated Fatty Acids Restores Normal Emotional Behaviors in Autoimmune-Prone BAFF Transgenic Mice
03:00 PM - 07:30 PM Abstract 220 - BAF312, a Potent and Selective S1P1/5 Receptor Modulator Reverses Ongoing Chronic EAE in Mice
03:00 PM - 07:30 PM Abstract 221 - In Vivo Characterization of the Therapeutic Effect of Glatiramer Acetate in Experimental Autoimmune Encephalomyelitis by Magnetic Resonance Imaging (MRI)
03:00 PM - 07:30 PM Abstract 222 - Mouse Loci Influencing Inflammatory Demyelinating Disease: Shared Synteny between Tmevd2/Eae3 and the MS Locus on Chr 1 Identified by Admixture Mapping
03:00 PM - 07:30 PM Abstract 223 - Sustained Release Fampridine Improves Walking Speed across a Wide Range of Baseline Deficits: Pooled Data from Three Placebo-Controlled Studies in Patients with Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 224 - Does Benign Form of Neuromyelitis Optica Exist?
03:00 PM - 07:30 PM Abstract 225 - Identifying Factors That Determine Disease Susceptibility in C57BL/6 Mice for Adoptive Transfer of Experimental Autoimmune Encephalomyelitis
03:00 PM - 07:30 PM Abstract 226 - Central Motor Conduction Failure Examined with the Triple Stimulation Technique Correlates with Pyramidal Tract Dysfunction and Disability in Patients with Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 227 - CMV Infection Modulates the Disease Course of TMEV Induced Demyelinating Disease in SJL/J Mice
03:00 PM - 07:30 PM Abstract 228 - Cytochrome C Deficiency Ameliorates Neurodegeneration in Animal Models of Amyotrophic Lateral Sclerosis and Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 229 - Serum Phosphorylated Neurofilament Heavy Chain Is a Marker of Axonal Loss in Experimental Optic Neuritis
03:00 PM - 07:30 PM Abstract 230 - Mercury Increases Th17 Polarization and Exacerbates Experimental Autoimmune Encephalomyelitis: Dependence on Matrix Metalloproteinase-9
03:00 PM - 07:30 PM Abstract 231 - Etiology of Exaggerated Axon Loss in MAGKO Mice with EAE: Activated Microglia Laying in Wait?
03:00 PM - 07:30 PM Abstract 232 - Specific Regulation of CD4 T Cells during Autoimmune Demyelination by microRNA
03:00 PM - 07:30 PM Abstract 233 - Estrogen Dependent Attenuation of EAE in a Transgenic Mouse Expressing the RNA Regulator, HuR, in Astrocytes
03:00 PM - 07:30 PM Abstract 235 - Relationship between Microstructural Degeneration of the Corpus Callosum, White Matter Hyperintensities, and Executive Function in Cognitively Intact Elderly
03:00 PM - 07:30 PM Abstract 236 - Aging and Gender Effects on the Cortical Anatomical Network Efficiency
03:00 PM - 07:30 PM Abstract 237 - Distinct White Matter Tract Changes in Frontotemporal Dementia Associated with FTLD and Alzheimer's Disease Pathology or CSF Biomarkers
03:00 PM - 07:30 PM Abstract 238 - Structural Correlates of Memory Performance with Diffusion Tensor Imaging
03:00 PM - 07:30 PM Abstract 239 - The Effect of Memantine on the Activity of the Resting Working Memory Network in Alzheimer's Disease
03:00 PM - 07:30 PM Abstract 240 - Age Effect on Functional Connectivity
03:00 PM - 07:30 PM Abstract 241 - White Matter Integrity Accounts for Reaction Time in Older Adults
03:00 PM - 07:30 PM Abstract 242 - Early and Late Onset Alzheimer's Disease Patients Have Distinct Patterns of White Matter Damage
03:00 PM - 07:30 PM Abstract 243 - Evidence for Brain White Matter Damage and Atrophy with Aging: A Diffusion Tensor MRI Tractography Study
03:00 PM - 07:30 PM Abstract 244 - Regional Relation of Gray Matter Atrophy with Corpus Callosum Alteration in Normal, MCI, and AD
03:00 PM - 07:30 PM Abstract 245 - Telcagepant Does Not Reduce Exercise Tolerance in Patients with Exercise Induced Myocardial Ischemia
03:00 PM - 07:30 PM Abstract 246 - Cutaneous Allodynia as a Prognostic Factor in the Treatment of Migraine with Botulinum Toxin
03:00 PM - 07:30 PM Abstract 247 - Does Gender Affect Efficacy and Tolerability of SumaRT/Nap during the Early Intervention Treatment of Migraine?
03:00 PM - 07:30 PM Abstract 248 - Headache Prophylaxis Using Combination Therapy - A Statistical Modeling Study
03:00 PM - 07:30 PM Abstract 249 - Experience with Botulinum Toxin Type A in the Treatment of Medically Intractable Pediatric Chronic Daily Headache
03:00 PM - 07:30 PM Abstract 250 - OnabotulinumtoxinA for Treatment of Chronic Migraine: Analysis of the 56-Week PREEMPT 1 Trial
03:00 PM - 07:30 PM Abstract 251 - OnabotulinumtoxinA for Treatment of Chronic Migraine: Analysis of the 56-Week PREEMPT 2 Trial
03:00 PM - 07:30 PM Abstract 253 - OnabotulinumtoxinA for Chronic Migraine: PREEMPT Trials Establish a Safe and Effective Dose and Injection Paradigm
03:00 PM - 07:30 PM Abstract 254 - Antialgic Effect of Low Intensity Laser in the Treatment of Cervicogenic Headaches
03:00 PM - 07:30 PM Abstract 255 - Acute Medication Use Patterns in Episodic Migraine: Results of the American Migraine Prevalence and Prevention Study (AMPP)
03:00 PM - 07:30 PM Abstract 256 - Spreading Depression: The Effects of Antiepileptic Drugs Used in Migraine Prophylaxis
03:00 PM - 07:30 PM Abstract 257 - Is Telcagepant Effective in Migraineurs Who Previously Used Opioids?
03:00 PM - 07:30 PM Abstract 258 - Fungal Sinusitis: A Surgically Treatable Cause of Chronic Daily Headache
03:00 PM - 07:30 PM Abstract 259 - Efficacy of Enalapril in Migraine Prophylaxis: Does It Work through Endothelial Dysfunction Recovery?
03:00 PM - 07:30 PM Abstract 260 - Intravenous Valproate Sodium Aborts Migraine Headaches Rapidly
03:00 PM - 07:30 PM Abstract 261 - Acute Anti-Migraine Efficacy and Tolerability of Zelrix[trade], a Novel Iontophoretic Transdermal Patch of Sumatriptan
03:00 PM - 07:30 PM Abstract 262 - Bilateral Masseter and Temporalis Hypertrophy: Case Report and Review of Literature
03:00 PM - 07:30 PM Abstract 263 - Pulse IV Steroid and IV Valproate Combination Therapy for Sustained Relief of Chronic, Treatment Refractory Headaches in Patients with Psychiatric Disorders
03:00 PM - 07:30 PM Abstract 264 - Regression of Chronic Migraine and High Frequency Episodic Migraine to Low Frequency Migraine through Surgery
03:00 PM - 07:30 PM Abstract 265 - Spontaneous Retinal Venous Pulsations as a Window to CSF Pressures - Are They Reliable?
03:00 PM - 07:30 PM Abstract 266 - A Case of Multiple Cranial Neuropathies from Perineural Spread of a Non-Melanoma Skin Cancer
03:00 PM - 07:30 PM Abstract 267 - Serial Polysomnography in Hypnic Headache Shows No Association with REM Sleep
03:00 PM - 07:30 PM Abstract 268 - Reversible Cerebral Vasoconstriction (RCVS) in Children and Adolescents (C/A): Its Role in Thunderclap Headaches
03:00 PM - 07:30 PM Abstract 269 - Osmophobia Is Increased in Menstrually Associated Migraine
03:00 PM - 07:30 PM Abstract 270 - Cardiac Autonomic Dysfunctions in Migraine Attack
03:00 PM - 07:30 PM Abstract 271 - A Tale of Two Systems: Cardiac Cephalalgia vs. Neurologic Cardiodynia
03:00 PM - 07:30 PM Abstract 272 - Onset and Potential Initiating Factors in New Daily-Persistent Headache
03:00 PM - 07:30 PM Abstract 273 - Relationship between Headache Frequency and Migraine-Related Disability in the International Burden of Migraine Study (IBMS)
03:00 PM - 07:30 PM Abstract 274 - The Effect of Serum Glucose Level on Cerebrovascular Reactivity to CO2 in Women with Migraine without Aura: Transcranial Doppler Study Using Breath Holding Method
03:00 PM - 07:30 PM Abstract 275 - Impact of Nutritional Factors on the Prevalence of Headache or Migraine
03:00 PM - 07:30 PM Abstract 276 - Rates and Predictors of Remission from Chronic Migraine (CM) to Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention (AMPP) Study
03:00 PM - 07:30 PM Abstract 277 - Prevalence of Chronic Daily Headaches as a Function of Parental Headache Status - Results from the Attention Brazil Project
03:00 PM - 07:30 PM Abstract 278 - PTSD, Drug Abuse, and Migraine: New Findings from the National Comorbidity Survey Replication (NCS-R)
03:00 PM - 07:30 PM Abstract 279 - Cutaneous Allodynia - A Predictor of Migraine Chronification: A Longitudinal Population-Based Study
03:00 PM - 07:30 PM Abstract 280 - Results from an International Observational Study of Pregnancy Outcomes Following Exposure to Sumatriptan, Naratriptan or the Fixed Dose Tablet Sumatriptan and Naproxen Sodium (SumaRT/Nap)
03:00 PM - 07:30 PM Abstract 281 - Natural History of Post Traumatic Headache: Prevalence, Impact, and Clinical Characteristics
03:00 PM - 07:30 PM Abstract 282 - An Analysis of Practice Guidelines on Headache Published by 好色先生
03:00 PM - 07:30 PM Abstract 283 - New Daily Persistent Headaches (NDPH) - Follow Up and Outcome in Children and Adolescents (C/A)
03:00 PM - 07:30 PM Abstract 284 - Body Mass Index (BMI) and Migraine in the Korean Population
03:00 PM - 07:30 PM Abstract 285 - Temporomandibular Disorders, Headache Status and Headache Frequency: A Population-Based Study
03:00 PM - 07:30 PM Abstract 286 - Sex Hormone Receptor Gene Polymorphisms and Migraine: A Systematic Review and Meta-Analysis
03:00 PM - 07:30 PM Abstract 287 - Relationship between Migraine Status and Functional Outcome from Stroke
03:00 PM - 07:30 PM Abstract 288 - Acute Treatment of Migraine in Patients with Cardiovascular Disease or Risk Factors
03:00 PM - 07:30 PM Abstract 289 - 5-HTTLPR Polymorphism in the Serotonin Transporter Gene and Migraine: A Systematic Review and Meta-Analysis
03:00 PM - 07:30 PM Abstract 290 - Caffeine Intake in Adolescents upon First Visit to Headache Specialty Center
03:00 PM - 07:30 PM Abstract 291 - Association between Socioeconomic Status and Migraine with and without Aura
03:00 PM - 07:30 PM Abstract 292 - Field Testing Chronic Migraine Criteria in the Population: Results of the German Headache Consortium (GHC) Study
03:00 PM - 07:30 PM Abstract 293 - Triptan Use as a Function of Cardiovascular Risk. A Population-Based Study
03:00 PM - 07:30 PM Abstract 294 - Prenatal Tabagism and Alcohol Intake Are Associated with Chronic Daily Headache at Childhood. A Population-Based Study
Faculty Disclosures
Gene Y. Sung, MD, MPH The institution of Dr. Sung has received research support from NIH.
Mindy A. Aisen, MD No disclosure on file
Jeffrey L. Cummings, MD, FAAN Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Actinogen, Acumen, AlphaCognition, ALZpath, Aprinoia, AriBio, Artery, Biogen, Biohaven, BioVie, BioXcel, Bristol-Myers Squib, Cassava, Cerecin, Diadem, Eisai, GAP Foundation, GemVax, Janssen, Jocasta, Karuna, Lighthouse, Lilly, Lundbeck, LSP/eqt, Mangrove Therapeutics, Merck, NervGen, New Amsterdam, Novo Nordisk, Oligomerix, ONO, Optoceutics, Otsuka, Oxford Brain Diagnostics, Prothena, ReMYND, Roche, Sage Therapeutics, Signant Health, Simcere, sinaptica, Suven, TrueBinding, Vaxxinity, and Wren pharmaceutical, assessment, and investment companies. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia, Biogen, Genentech, Grifols, Janssen, Karuna, Otsuka, reMYND, Roche, Signant Health. Dr. Cummings has stock in Artery, Vaxxinity, Behrens, Alzheon, MedAvante-Prophase, and Acumen. Dr. Cummings has received research support from NIH. Dr. Cummings has received research support from NIGMS. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
Jeffrey A. Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
David W. Dodick, MD, FAAN Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical 好色先生 Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with 好色先生 that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Stephen D. Silberstein, MD, FAAN Dr. Silberstein has received publishing royalties from a publication relating to health care.
Fred D. Sheftell, MD No disclosure on file
David J. Capobianco, MD, FAAN No disclosure on file
Kenneth C. Gorson, MD Dr. Gorson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Gorson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Gorson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Gorson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
James J. Corbett, MD No disclosure on file
Karl D. Kieburtz, MD Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation.
Henry F. McFarland, MD Dr. McFarland has received intellectual property interests from a discovery or technology relating to health care. Dr. McFarland has received personal compensation in the range of $50,000-$99,999 for serving as a Medical Director with Cumming Foundation.
David S. Saperstein, MD No disclosure on file
Marcelo E. Bigal, MD, PhD No disclosure on file
Daniel Woo, MD, FAAN The institution of Dr. Woo has received research support from NIH.
Stephen L. Hauser, MD Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Phillip A. Low, MD, FAAN Dr. Low has nothing to disclose.
Charles S. DeCarli, MD, FAAN Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH.
Richard A. Lewis, MD, FAAN Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nuvig. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioCryst. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervoSave. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TGTX. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer-Ingleheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cartesian. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CME Outfitters. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVision. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Up to Date. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Shernoff et al. Dr. Lewis has received publishing royalties from a publication relating to health care.
Kyra J. Becker, MD No disclosure on file
Barry S. Oken, MD, PhD, FAAN Dr. Oken has nothing to disclose.
Randolph B. Schiffer, MD No disclosure on file
Anthony A. Amato, MD, FAAN Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Caballeta. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Amato has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian Therapeutics. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medpace. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Amato has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for legal firms. The institution of Dr. Amato has received research support from NIH. Dr. Amato has received publishing royalties from a publication relating to health care.
Randall T. Schapiro, MD, FAAN No disclosure on file
A. Gordon Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US Department of Justice. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Lexicon. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Smith has received research support from NIH (NINDS, NIDDK). Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a Study Section with NIH.
Sheena K. Aurora, MD Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
J. R. Singleton, MD Dr. Singleton has received research support from NIH.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Joseph E. Parisi, MD Dr. Parisi has nothing to disclose.
Brian G. Weinshenker, MD, FAAN Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zenas Pharma. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Denise H. Rhoney, PhD No disclosure on file
Brett M. Kissela, MD, MS, FAAN The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to AAN interests or activities.
Rodger J. Elble, MD, PhD, FAAN Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage . Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ES Therapeutics. Dr. Elble has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Applied Therapeutics. Dr. Elble has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis.
Norman Latov, MD, PhD Dr. Latov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Polyneuron. Dr. Latov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Therapath LLC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Mcaloon & Freeman, PC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conway Homer PC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sylvia Chin-Kaplan, LLC. The institution of Dr. Latov has received research support from Takeda. Dr. Latov has received publishing royalties from a publication relating to health care.
Emma Ciafaloni, MD, FAAN Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Andrew R. Pachner, MD No disclosure on file
Lael Stone, MD No disclosure on file
Richard A. Rudick, MD, FAAN Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Ninan T. Mathew, MD No disclosure on file
Fred D. Lublin, MD, FAAN Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
W. T. Longstreth, Jr., MD, FAAN The institution of Dr. Longstreth has received research support from NIH.
Mark J. Kupersmith, MD, FAAN Dr. Kupersmith has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal firms. Dr. Kupersmith has stock in SafeTherapeutics m,LLC. The institution of Dr. Kupersmith has received research support from NEI, NYEEI FDN, Shulman Family NAION fund. Dr. Kupersmith has received intellectual property interests from a discovery or technology relating to health care.
Mark A. Ferrante, MD, FAAN No disclosure on file
Deborah I. Friedman, MD, MPH, FAAN Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Friedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsone. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology . Dr. Friedman has a non-compensated relationship as a Program Co-Chair, Scottsdale Headache Symposium with American Headache Society that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Medical Advisor with Spinal CSF Leak Foundation that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a President-elect, Board of Directors with Southern Headache Society that is relevant to AAN interests or activities.
Ludwig Gutmann, MD, FAAN Dr. Gutmann has a non-compensated relationship as a senior consulting editor (Humanities) with NEUROLOGY that is relevant to AAN interests or activities.
J. P. Mohr, MD, FAAN The institution of Dr. Mohr has received research support from NINDS Grant R01 NS099268 NIH-NINDS .
John W. Griffin, MD No disclosure on file
Hillel S. Panitch, MD No disclosure on file
Scott E. Kasner, MD, FAAN Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Javelin. Dr. Kasner has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Kasner has received research support from WL Gore. The institution of Dr. Kasner has received research support from DiaMedica. The institution of Dr. Kasner has received research support from Bayer.
Andrew D. Goodman, MD, FAAN Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono.
Nancy D. Richert, MD, PhD No disclosure on file
Peter A. Calabresi, MD, FAAN Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Robert D. Brown, Jr., MD, MPH, FAAN Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
David Langer, MD No disclosure on file
James M. Gilchrist, MD, FAAN Dr. Gilchrist has received publishing royalties from a publication relating to health care.
F. M. Cutrer, MD Dr. Cutrer has received publishing royalties from a publication relating to health care.
Latisha Sharma, MD Dr. Sharma has nothing to disclose.
Nerses Sanossian, MD, FAAN Dr. Sanossian has received personal compensation for serving as an employee of Univeristy of Southern California. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Sanossian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Portola. The institution of Dr. Sanossian has received research support from Diffusion Pharma.
Julius Latorre, MD, FAAN Dr. Latorre has nothing to disclose.
Jennifer J. Majersik, MD, FAAN Dr. Majersik has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Majersik has received research support from NIH/NINDS. The institution of Dr. Majersik has received research support from NIH/NCATS.
Theodore R. Brown, MD Dr. Brown has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astellas. The institution of Dr. Brown has received research support from Merck.
Lloyd H. Kasper, MD No disclosure on file
Lan Zhou, MD, PhD The institution of Dr. Zhou has received research support from NIH.
Michele Yang, MD The institution of Dr. Yang has received research support from Janssen. The institution of Dr. Yang has received research support from Edgewise. The institution of Dr. Yang has received research support from ReveraGen.
Christopher J. Boes, MD, FAAN Dr. Boes has a non-compensated relationship as a Review Committee for Neurology member with ACGME that is relevant to AAN interests or activities.
Gisele R. Oliveira, MD No disclosure on file
Christiane Wegner, MD No disclosure on file
Olaf Stuve, MD, PhD, FAAN Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
Patrick M. Grogan, MD, FAAN No disclosure on file
Neeraj Kumar, MD Dr. Kumar has nothing to disclose.
Alan J. Thompson, MD, FRCP, FAAN No disclosure on file
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Steven R. Messe, MD, FAHA, FAAN Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Terumo. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WL Gore. The institution of Dr. Messe has received research support from WL Gore. The institution of Dr. Messe has received research support from Mallinkrodt. The institution of Dr. Messe has received research support from Biogen. Dr. Messe has received intellectual property interests from a discovery or technology relating to health care. Dr. Messe has received publishing royalties from a publication relating to health care. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving as a Clinical Event Committee for the CONFORMAL left atrial appendage occlusion trial with Yale Cardiovascular Research Group.
Kazim A. Sheikh, MD The institution of Dr. Sheikh has received research support from NIH. The institution of Dr. Sheikh has received research support from DoD.
Glenn Lopate, MD Dr. Lopate has nothing to disclose.
Ilya Kister, MD, FAAN Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Deborah H. Hall, MD, PhD, FAAN Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Charlene E. Hafer-Macko, MD No disclosure on file
Alireza Minagar, MD No disclosure on file
Benjamin R. Brooks, MD, FAAN Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with 好色先生 that is relevant to AAN interests or activities.
Christina Caon, RN, BS Ms. Caon has received personal compensation for serving as an employee of EMD Serono.
Erin K. O'Ferrall, MD The institution of Dr. O'Ferrall has received research support from Sanofi Genzyme. The institution of Dr. O'Ferrall has received research support from Harmony Biosciences. The institution of Dr. O'Ferrall has received research support from Fulcrum Therapeutics. The institution of Dr. O'Ferrall has received research support from Roche Pharmaceuticals. The institution of Dr. O'Ferrall has received research support from VERTEX. The institution of Dr. O'Ferrall has received research support from Novartis. Dr. O'Ferrall has received publishing royalties from a publication relating to health care.
Michael J. Polydefkis, MD, FAAN Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceutical . Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Murray Grossman, MD, FAAN Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
John Cole, MD Dr. Cole has nothing to disclose.
Christopher J. Klein, MD, FAAN Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Tobias Kurth, MD, ScD, FAAN Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TotalEnergies. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly & Company. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ. Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. The institution of Dr. Kurth has received research support from German Joint Committee. The institution of Dr. Kurth has received research support from Ministry of Health.
Laurie Gutmann, MD, FAAN The institution of Dr. Gutmann has received research support from NIH. The institution of Dr. Gutmann has received research support from Harmony . Dr. Gutmann has received publishing royalties from a publication relating to health care.
Michael Sinnreich, MD, PhD Prof. Sinnreich has nothing to disclose.
Saud Sadiq, BS, FAAN Ms. Brewi has nothing to disclose.
Michelle L. Mauermann, MD, FAAN The institution of Dr. Mauermann has received research support from Intellia. Dr. Mauermann has received publishing royalties from a publication relating to health care.
Stephanie Scala No disclosure on file
Mamatha Pasnoor, MD, FAAN Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Mamta Verma, MD No disclosure on file
Ivan Garza, MD, FAAN No disclosure on file
No disclosure on file
Gilles Defer, MD Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Radi S. Shahien, MD Dr. Shahien has nothing to disclose.
Joerg R. Kraus, MD No disclosure on file
Emilien Delmont, MD No disclosure on file
Erin Furr-Stimming, MD, FAAN Dr. Furr-Stimming has received personal compensation for serving as an employee of Help4HD International. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedPage. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atalanta Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SkyHawk Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atalanta Therapeutics. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine Bioscienes. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. The institution of Dr. Furr-Stimming has received research support from HDSA. The institution of Dr. Furr-Stimming has received research support from Prilennia. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has a non-compensated relationship as a Committee member with AAN UES Committee that is relevant to AAN interests or activities.
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Denise I. Campagnolo, MD, MS Dr. Campagnolo has received personal compensation for serving as an employee of Biogen. Dr. Campagnolo has received stock or an ownership interest from Biogen.
Kenkichi Nozaki, MD No disclosure on file
Alicja Lerner, MD No disclosure on file
Christian Lampl, MD, PhD No disclosure on file
Nicolette C. Notermans, MD, PhD No disclosure on file
Roberta Frigerio, MD Dr. Frigerio has nothing to disclose.
Karen C. Albright, DO, DO, PhD, MS, MPH Dr. Albright has nothing to disclose.
Keith R. Edwards, MD, FAAN No disclosure on file
Charlene R. Hoffman-Snyder, DNP No disclosure on file
Lucien Rumbach, MD No disclosure on file
Elissaios Karageorgiou, MD, PhD, FAAN Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrtelle. The institution of Dr. Karageorgiou has received research support from European Union.
Clementine Karageorgiou, MD The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.
Shahram Attarian, MD, PhD Prof. Attarian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI, Pfizer LFB, Alnylam Biogen Argenx, UCB Alexion, Astrazenica, Amicus, Janssen, Novartis, Roche. Prof. Attarian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SANOFI, Biogen,Alnylam, Argenx, USB, Alexion Astrazenica, Janssen, Roche, Amgen. The institution of Prof. Attarian has received research support from National Institut of Health .
Vahid Shaygan Nejad, MD Dr. Shaygan Nejad has nothing to disclose.
John Q. Trojanowski, MD, PhD Dr. Trojanowski has nothing to disclose.
Dong Jin Shin, MD Dr. Shin has nothing to disclose.
Peter H. King, MD The institution of Dr. King has received research support from Department of Veterans Affairs. The institution of Dr. King has received research support from NIH.
Deborah Reed, MD No disclosure on file
Annie Verschueren No disclosure on file
Olivier Heinzlef, MD Dr. Heinzlef has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Heinzlef has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Heinzlef has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Edimark.
Pedro A. Kowacs, MD, FAAN Dr. Kowacs has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Giovanni Savettieri, MD No disclosure on file
Roberto D'Alessandro, MD No disclosure on file
Hayrettin Tumani, MD Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Frederik Barkhof, MD, PhD Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Richard Walsh, MD Dr. Walsh has nothing to disclose.
Fereshteh Ashtari Fereshteh Ashtari has nothing to disclose.
Enrico Ferrante No disclosure on file
Robert Kane, PhD, ABPP-CN No disclosure on file
Cynthia L. Sullivan, PhD No disclosure on file
Jeffrey A. Wilken, PhD No disclosure on file
Paul W. O'Connor, MD No disclosure on file
Ludwig Kappos, MD, FAAN Dr. Kappos has nothing to disclose.
Arnaud Lacour No disclosure on file
Kwang-Soo Lee, MD No disclosure on file
Byung-kun Kim, MD Dr. Kim has nothing to disclose.
Muhammad F. Suri, MD Dr. Suri has nothing to disclose.
Juan J. Figueroa, MD No disclosure on file
Adilia M. Hormigo, MD, PhD Dr. Hormigo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TargTex.
Benjamin M. Greenberg, MD, FAAN Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Beth B. Hogans, MD, PhD Dr. Hogans has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Academy of Pain Medicine. The institution of Dr. Hogans has received research support from VA Office of Research and Development. Dr. Hogans has received intellectual property interests from a discovery or technology relating to health care. Dr. Hogans has received publishing royalties from a publication relating to health care. Dr. Hogans has received publishing royalties from a publication relating to health care. Dr. Hogans has a non-compensated relationship as a Grant reviewer with Veterans Affairs Office of Research and Development that is relevant to AAN interests or activities. Dr. Hogans has a non-compensated relationship as a Grant reviewer with National Institutes of Health that is relevant to AAN interests or activities.
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Shrikant Mishra, MD Dr. Mishra has nothing to disclose.
X. Henry Hu, MD, PhD No disclosure on file
Alexandros C. Tselis, MD, PhD No disclosure on file
Carl Dahlof No disclosure on file
Michael L. Reed, PhD The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.
Eva Havrdova, MD Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
P. James B. Dyck, MD, FAAN Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Robert Spinner No disclosure on file
Kimberly Amrami, MD Kimberly Amrami, MD has nothing to disclose.
David D. Adams David D. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALNYLAM. David D. Adams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Michelle Lener, PharmD No disclosure on file
Catherine C. Turkel, Pharm No disclosure on file
Chris H. Polman, MD No disclosure on file
Neeta Garg, MD Dr. Garg has nothing to disclose.
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Istvan Pirko, MD, FAAN No disclosure on file
Aaron J. Johnson No disclosure on file
Ignacio F. Casas-Parera, MD, PhD, FAAN Dr. Casas-Parera has received publishing royalties from a publication relating to health care.
Owen T. Carmichael, PhD No disclosure on file
Fortunato Battaglia, MD Dr. Battaglia has nothing to disclose.
Daniel R. Wynn, MD Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mylan. Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Wynn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner Life. Dr. Wynn has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Biogen. The institution of Dr. Wynn has received research support from Novartis. The institution of Dr. Wynn has received research support from Sanofi. The institution of Dr. Wynn has received research support from Adamas Pharmaceutics. The institution of Dr. Wynn has received research support from EMD Serono. The institution of Dr. Wynn has received research support from Roche. Dr. Wynn has a non-compensated relationship as a Director, Consultants in Neurology Comprehensive Care Center with National MS Society that is relevant to AAN interests or activities.
Joseph Herbert, MD No disclosure on file
Manuela Vaneckova Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Manuela Vaneckova has received research support from Czech Ministry of Health project—grants NU 22-04-00193 . Manuela Vaneckova has received research support from Czech Ministry of Health project - RVO VFN 64165 . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving as a principal investigator with Czech Ministry of Health project—grants NU 22-04-00193 .
Karine Viala No disclosure on file
Carlo Cereda, MD No disclosure on file
Haluk Topaloglu, MD No disclosure on file
Brian McNamara, MD Dr. McNamara has nothing to disclose.
Luci Blasucci, RN No disclosure on file
Christine Stadelmann-Nessler No disclosure on file
Jayawant N. Mandrekar, PhD Dr. Mandrekar has nothing to disclose.
Cristiane R. Afonso, MD No disclosure on file
Kyung Mi Oh, MD No disclosure on file
Carlos A. Pardo-Villamizar, MD The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Fadi B. Nahab, MD Dr. Nahab has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Consultation. Dr. Nahab has received intellectual property interests from a discovery or technology relating to health care.
Mary M. Machulda, PhD The institution of Dr. Machulda has received research support from NIH.
Richard K. Kim, MD Dr. Kim has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for RKK Consulting, Inc..
Erik P. Pioro, MD, DPhil, FAAN Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanir Pharmaceutical, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTherapia, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma America, Inc..
Gina Remington No disclosure on file
David R. Cornblath, MD Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cigna. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anavex. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MPTP. Dr. Cornblath has received intellectual property interests from a discovery or technology relating to health care.
Scott Przybelski Scott Przybelski has nothing to disclose.
Michael R. Frankel, MD The institution of Dr. Frankel has received research support from Nico Corporation, Inc.
David G. Munoz, MD No disclosure on file
Jin J. Luo, MD, PhD, FAAN Dr. Luo has nothing to disclose.
Peter J. Dyck, MD, FAAN Dr. Dyck has nothing to disclose.
Gigi J. Ebenezer, MBBS No disclosure on file
Tarvez Tucker, MD No disclosure on file
Michael McDermott No disclosure on file
Donald S. McCorquodale III, MD, PhD No disclosure on file
Victoria Lawson, MD, FAAN Dr. Lawson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Ted Phillips, MD No disclosure on file
Nancy Monson Nancy Monson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Nancy Monson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenrAb, Inc.. Nancy Monson has stock in GenrAb, Inc.. The institution of Nancy Monson has received research support from NIH. Nancy Monson has received intellectual property interests from a discovery or technology relating to health care.
Russell L. Chin, MD No disclosure on file
Marco D'Amelio, MD No disclosure on file
Paolo Ragonese No disclosure on file
Ramesh Madhavan, MD, FAAN Dr. Madhavan has received stock or an ownership interest from TiaTech USA and TiaTech India. Dr. Madhavan has received intellectual property interests from a discovery or technology relating to health care.
Bjarne A. Udd, MD No disclosure on file
Lars G. Edstrom, MD, FAAN No disclosure on file
Thomas A. Berger, MD Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Darren P. Baker, PhD Dr. Baker has received personal compensation for serving as an employee of Sanofi. Dr. Baker has received stock or an ownership interest from Sanofi.
Lisa Silbert, MD, FAAN The institution of Dr. Silbert has received research support from the NIH. Dr. Silbert has received personal compensation in the range of $0-$499 for serving as a Peer Reviewer, study section with NIH.
Francesca Bagnato, MD Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyne. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jenseen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk-Serono.
Joan M. Ohayon Joan M. Ohayon has nothing to disclose.
Marco Riva No disclosure on file
Vasiliki N. Ikonomidou No disclosure on file
Edward J. Cupler, MD, FAAN Dr. Cupler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Timothy E. Lotze, MD, FAAN Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Erica Rojas-Bilbao, MD No disclosure on file
Minesh Khatri No disclosure on file
Melina Jones, PhD No disclosure on file
Dominik S. Meier, PhD No disclosure on file
Dawn O. Kleindorfer, MD, FAAN Dr. Kleindorfer has nothing to disclose.
Pooja Khatri, MD, FAAN The institution of Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bayer. The institution of Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Kathleen Alwell No disclosure on file
John W. Rose, MD, FAAN The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Xin Liu No disclosure on file
Adnan Safdar, MD Dr. Safdar has nothing to disclose.
Leonard van den Berg, MD The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Tjalf Ziemssen, MD, FAAN Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Andrew M. Blumenfeld, MD, FAAN Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Axsome. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cedar Sinai. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AXSOME.
H. R. Jones, Jr., MD No disclosure on file
Brian Scott, MD Dr. Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Legend Biotech.
Jayne Ness, MD An immediate family member of Dr. Ness has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jan One. The institution of Dr. Ness has received research support from Chugai/Roche. The institution of Dr. Ness has received research support from National Multiple Sclerosis Society. The institution of an immediate family member of Dr. Ness has received research support from NIH. An immediate family member of Dr. Ness has received publishing royalties from a publication relating to health care.
Susan E. Goelz, PhD No disclosure on file
Angela L. Genge, MD Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa.
Ruxandra M. Costa, MD No disclosure on file
Alexandre Eusebio, MD No disclosure on file
Michael Wall, MD, FAAN No disclosure on file
Pieter Van Doorn, MD The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grifols. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Van Doorn has received publishing royalties from a publication relating to health care.
Ingemar S. Merkies, MD No disclosure on file
Patricia Tourniaire, MD No disclosure on file
Tony W. Ho, MD No disclosure on file
Sunitha Santhakumar, MD No disclosure on file
Min-Suk Yoon, MD No disclosure on file
Lenore J. Launer, PhD No disclosure on file
Mark Obermann, MD, FAAN No disclosure on file
Pierre Duquette, MD The institution of Dr. Duquette has received research support from Biogen and Genzyme.
Stanley J. Iyadurai, MD, PhD, FAAN Dr. Iyadurai has received personal compensation for serving as an employee of Catalyst Pharmaceuticals. Dr. Iyadurai has received stock or an ownership interest from Catalyst Pharmaceuticals.
Lawrence Marinucci No disclosure on file
Frederick J. Derosier, DO No disclosure on file
Minhua Yang No disclosure on file
Jan Krasensky, MD No disclosure on file
William F. Schmalstieg, MD No disclosure on file
Amy Pace, ScD No disclosure on file
Ron Cohen, MD Dr. Cohen has received personal compensation for serving as an employee of Acorda Therapeutics. Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for VBL Therapeutics. Dr. Cohen has stock in Acorda Therapeutics.
Andrew Blight, PhD No disclosure on file
Mario O. Melcom, MD No disclosure on file
Dessa Sadovnick, PhD No disclosure on file
Sylvia M. Lucas, MD, PhD No disclosure on file
Bruce L. Hughes, MD, FAAN No disclosure on file
Mark Gudesblatt, MD The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Staley A. Brod, MD Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi.
Daniel Gendron, MD No disclosure on file
Angelika F. Hahn, MD, FRCP(C) No disclosure on file
Bhupendra O. Khatri, MD, FAAN Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ER Squibb (Bristol Myer Squibb). Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizone. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyne. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seronoe. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for E.R. Squibb. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutic. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx US. The institution of Dr. Khatri has received research support from Biogen.
Thomas K. Koch, MD Dr. Koch has nothing to disclose.
Neil W. Kowall, MD Dr. Kowall has received publishing royalties from a publication relating to health care.
Ann C. McKee, MD Dr. McKee has nothing to disclose.
Vijay M. Thadani, MD No disclosure on file
Kenneth J. Mack, MD, PhD, FAAN Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Mack has received publishing royalties from a publication relating to health care. Dr. Mack has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Witness with Department of Justice, DVIC.
Bibhuti Mishra, MD No disclosure on file
Walter F. Haupt, MD, Prof, FAAN No disclosure on file
Giuseppe Salemi, MD No disclosure on file
David J. Libon, PhD No disclosure on file
Anne M. Murray, MD No disclosure on file
Dimos Dimitrios D. Mitsikostas, MD, PhD The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Leli Lilly. The institution of Dr. Mitsikostas has received research support from Eli Lilly. Dr. Mitsikostas has a non-compensated relationship as a Co-Chair of Headache Panel with EAN that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a President with Hellenic Headache Society that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with J Headache Pain that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with Frontier Neurology that is relevant to AAN interests or activities.
Exuperio Diez-Tejedor, MD, PhD No disclosure on file
Andrew H. Chan, MD No disclosure on file
Roy H. Hamilton, MD, MS, FANA, FAAN Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highland Instruments. Dr. Hamilton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognito Therapeutics. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation. The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Department of Defense. The institution of Dr. Hamilton has received research support from Chan Zuckerberg Initiative.
Matthew E. Tilem, MD An immediate family member of Dr. Tilem has received personal compensation in the range of $100,000-$499,999 for serving as a Attorney with Pharmaceutical companies (confidential).
Catherine M. Dalton, MD No disclosure on file
James C. Watson, MD No disclosure on file
Sara C. Crystal, MD Dr. Crystal has received personal compensation for serving as an employee of Thirty Madison. Dr. Crystal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Crystal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Christian Grommes, MD Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BTG. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grommes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curis. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono.
Mona Bahouth, MD, PhD, FAAN The institution of Dr. Bahouth has received research support from NIH.
Noel Carlson, PhD The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
Zohara Sternberg, PhD No disclosure on file
Marianne C. Cunnington, PhD No disclosure on file
Crystal S. Fo, MD No disclosure on file
Edouard Hirsch No disclosure on file
Randall Kaye, MD No disclosure on file
Bing Zhu No disclosure on file
Opeolu Adeoye No disclosure on file
Sait Ashina, MD Dr. Ashina has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Ashina has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Ashina has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer.
Dawn C. Buse, PhD Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Catalina Cleves, MD Dr. Cleves has nothing to disclose.
Alasdair Coles, MD, PhD Dr. Coles has nothing to disclose.
Christopher Cunniff, MD No disclosure on file
Leah Gaedeke, MSN, FNP-BC No disclosure on file
JaNean Engelstad JaNean Engelstad has nothing to disclose.
Jerome Franques, MD No disclosure on file
Douglas Feinstein, MD No disclosure on file
Xiang Gao, MD, PhD Dr. Gao has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nutrition Journal. The institution of Dr. Gao has received research support from NIH.
Tracey D. Graves, MD, PhD, FRCP No disclosure on file
Sebastian Humpert, MD No disclosure on file
Anna Karydas No disclosure on file
Virginia Lee, PhD Virginia Lee, PhD has nothing to disclose.
Louis Manganas, MD, PhD No disclosure on file
Jeong-Ho Park, MD No disclosure on file
Jurriaan Peters, MD Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Peters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Peters has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for CRICO. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for UCB.
Simon Podnar, MD No disclosure on file
Andrea L. Rosso, MPH No disclosure on file
Samuel Singer, MD Dr. Singer has nothing to disclose.
Josephine K. Swanton, MD No disclosure on file
Marie Theaudin, MD No disclosure on file
Ivo N. Van Schaik, MD No disclosure on file
Prashanthi Vemuri, PhD The institution of Dr. Vemuri has received research support from NIH.
Nathan P. Staff, MD, PhD, FAAN Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health.
Dusan Stefoski, MD, FAAN No disclosure on file
Alan Z. Segal, MD, FAAN Dr. Segal has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Various Law Firms. Dr. Segal has received publishing royalties from a publication relating to health care.
Claude J. Desnuelle, MD No disclosure on file
Conrad Weihl, MD, PhD Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Casma therapeutics. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acceleron. Dr. Weihl has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wilson Elser Moskowitz Edelman & Dicker LLP.
Gail H. Marracci, PhD No disclosure on file
Stephanie Jurgensen, PhD No disclosure on file
Eduardo Nobile-Orazio, MD, PhD, FAAN Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX, Belgium. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB, France. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Switzerland. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen, USA. The institution of Dr. Nobile-Orazio has received research support from Takeda/Shire.
Fredric K. Cantor, MD, FAAN No disclosure on file
Virginia J. Howard, PhD The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH.
Thien T. Nguyen, MD No disclosure on file
Markus Schuerks, MD, FAAN No disclosure on file
Bridget T. Carey, MD No disclosure on file
Giuliana Galassi, MD No disclosure on file
Gudarz Davar, MD No disclosure on file
Sumit Parikh, MD Dr. Parikh has received personal compensation in the range of $0-$499 for serving as a Consultant for Epirium. The institution of Dr. Parikh has received research support from CHAMP. The institution of Dr. Parikh has received research support from Mitochondrial Medicine Society. The institution of Dr. Parikh has received research support from Minovia. The institution of Dr. Parikh has received research support from Acadia. The institution of Dr. Parikh has received research support from Stealth. Dr. Parikh has received publishing royalties from a publication relating to health care.
Augusto A. Miravalle, MD, FAAN Dr. Miravalle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Miravalle has received research support from Genzyme. The institution of Dr. Miravalle has received research support from EMD Serono. The institution of Dr. Miravalle has received research support from Alexion.
B. L. Peterlin, DO Dr. Peterlin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for J&J. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Annette Wundes, MD, FAAN The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Elisabeth A. Cats, MD No disclosure on file
Liat Hayardeny Nisimov, PhD No disclosure on file
Kerstin Hellwig Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
George J. Snipes, MD No disclosure on file
Mayowa Owolabi, MD, FAAN Dr. Owolabi has nothing to disclose.
Marcin P. Mycko, MD No disclosure on file
Nikita Tangella No disclosure on file
Michael Gruenthal, MD, PhD No disclosure on file
Sanne Piepers No disclosure on file
Uri Napchan, MD No disclosure on file
Mario Halfon No disclosure on file
Lakshmi Warrior, MD, FAAN Dr. Warrior has nothing to disclose.
Bruno Eymard, MD No disclosure on file
Michael J. Boivin No disclosure on file
Earl A. Zimmerman, MD, FAAN No disclosure on file
Judith Stephenson No disclosure on file
Declan T. Chard No disclosure on file
Doralina G. Brum No disclosure on file
Paolo F. Nichelli, MD No disclosure on file
Andre Maues De Paula, MD, PhD No disclosure on file
Bruno J. Giordani, PhD No disclosure on file
Francoise Bouhour No disclosure on file
Michal Szulc No disclosure on file
Judith Bellmann-Strobl, MD Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Judith Bellmann-Strobl, MD has received research support from Bayer. The institution of Judith Bellmann-Strobl, MD has received research support from NEMOS.
Christopher S. Nance, MD No disclosure on file
Na Tosha N. Gatson, MD, PhD, FAAN Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Menarini Silicon Biosystems. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvOx Pharmaceuticals. Dr. Gatson has received publishing royalties from a publication relating to health care. Dr. Gatson has a non-compensated relationship as a Board Member with Society for Equity in Neurosciences (SEQUINS) that is relevant to AAN interests or activities.
Sakhina Begum-Haque, PhD No disclosure on file
Daniel Mielcarz No disclosure on file
Ghazala Hayat, MBBS, FAAN Dr. Hayat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for kabafusion. Dr. Hayat has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for csl. Dr. Hayat has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Hayat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for MTPA. Dr. Hayat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for alexion. Dr. Hayat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for kabafusion.
Sureyya Dikmen, PhD No disclosure on file
Christine A. Matarese, DO No disclosure on file
Brajesh K. Agrawal, MD No disclosure on file
Rainer Apfel, MD No disclosure on file
Estefania Arroyo No disclosure on file
Pratik D. Bhattacharya, MD, MPH Dr. Bhattacharya has a non-compensated relationship as a Research Advisor with Defeat MSA Alliance 501 (c) (3) that is relevant to AAN interests or activities.
Thomas Brennan No disclosure on file
Mesha Gay Brown, MD Dr. Brown has nothing to disclose.
Barry Byrne Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rocket Pharma. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association.
Elijah Chaila, MD No disclosure on file
David Dolezil No disclosure on file
Benjamin Eckert No disclosure on file
Diana Ferraro, MD, PhD Dr. Ferraro has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Ferraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ferraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Ferraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Ferraro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ferraro has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Binding Site. Dr. Ferraro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Pamela Foulds, MD No disclosure on file
Giovanni B. Frisoni, MD No disclosure on file
M. Maria Glymour, PhD No disclosure on file
Wendy Golden, MD No disclosure on file
Mark Gorman, MD The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
Aiden Haghikia, MD Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. The institution of Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyverna. Dr. Haghikia has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Biogen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Celgene.
Daniel M. Harrison, MD, FAAN Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American College of Physicians. The institution of Dr. Harrison has received research support from Roche-Genentech. Dr. Harrison has received publishing royalties from a publication relating to health care.
Christophe Hotermans, MD, PhD No disclosure on file
Thomas J. Kaley, MD Dr. Kaley has received publishing royalties from a publication relating to health care.
Siobhan Kelly, MD Dr. Kelly has nothing to disclose.
Gyanendra Kumar, MD, FAAN Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Medical Consultant with Arizona Medical Board.
Gunther Ladurner, MD No disclosure on file
Alexander Landfield, MD No disclosure on file
Christopher Lines No disclosure on file
Anli Liu, MD Dr. Liu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ECRI. Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace Inc.
Aubrey Adams, PhD Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Rohit A. Marawar, MD, FAAN Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Peter A. Michas-Martin, MD No disclosure on file
Andre M. Mueller, PhD No disclosure on file
Babak Navi, MD Dr. Navi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MindRhythm Inc. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple medicolegal firms.
Ryan O'Donnell No disclosure on file
Javier Ochoa-Reparaz, PhD No disclosure on file
Dominick Paes No disclosure on file
Sandipan Pati, MD Dr. Pati has nothing to disclose.
Mahmoud Rayes, MD No disclosure on file
Jordan S. Reichman, MD No disclosure on file
Sandra R. Richman, MD No disclosure on file
Pamela Rist, PhD The institution of Dr. Rist has received research support from National Institutes of Health. The institution of Dr. Rist has received research support from Brigham and Women's Hospital. The institution of Dr. Rist has received research support from American Heart Association. The institution of Dr. Rist has received research support from Mars Edge.
Matthew S. Robbins, MD, FAAN Dr. Robbins has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Robbins has received publishing royalties from a publication relating to health care. Dr. Robbins has a non-compensated relationship as a Board of Directors member, 好色先生 Program speaker with American Headache Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Board of Directors member, 好色先生 Program speaker with New York State Neurological Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Editorial Board Member with Continuum, 好色先生 that is relevant to AAN interests or activities.
Megha Shah Megha Shah has received personal compensation for serving as an employee of AbbVie. Megha Shah has stock in AbbVIe .
Lakshmi Shankar, MD No disclosure on file
Fazeel M. Siddiqui, MD No disclosure on file
Andrew Solomon, MD, FAAN Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche . Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiniksa Pharmaceuticals . Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Solomon has received research support from Bristol Meyers Squibb.
Tracy E. Stites, PhD Dr. Stites has received personal compensation for serving as an employee of Novartis Pharmaceuticals. Dr. Stites has received stock or an ownership interest from Novartis Pharmaceuticals.
Meena Subramanyam, PhD No disclosure on file
Anna Tsakiri, MD No disclosure on file
Reva C. Wilheim No disclosure on file
Peter Wipfler Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Sibyl E. Wray, MD Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Stacy S. Wu, MD Dr. Wu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc. Dr. Wu has stock in Novartis.
Hussam A. Yacoub, DO Dr. Yacoub has nothing to disclose.
Xiaojun You, PhD No disclosure on file
Gang Zhang, MD, PhD No disclosure on file
Cecilia Grau Espinosa, PhD No disclosure on file
Valerie Jaillon Riviere, MD No disclosure on file
Amy E. Lovett Racke, PhD No disclosure on file
Ivo W. Tremont, MD, FAAN Dr. Tremont has nothing to disclose.
Karen Truitt, DO Dr. Truitt has stock in QTRX. Dr. Truitt has stock in EXAS. Dr. Truitt has stock in ACAD. Dr. Truitt has stock in ABBV. Dr. Truitt has stock in NVS. Dr. Truitt has stock in VRTX. Dr. Truitt has stock in MRK.
Rami Ausi, MD No disclosure on file
Shannon Kohake, MD No disclosure on file
Haythum O. Tayeb, MD Dr. Tayeb has nothing to disclose.
Wolfgang Brueck, PhD Dr. Brueck has nothing to disclose.
Adrian J. Hepner, MD No disclosure on file
Chamindra G. Laverty, MD The institution of Dr. Laverty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta . Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Laverty has received research support from Sarepta. The institution of Dr. Laverty has received research support from Novartis Gene Therapies. The institution of Dr. Laverty has received research support from Italfarmaco. The institution of Dr. Laverty has received research support from Fibrogen. The institution of Dr. Laverty has received research support from Avidity. The institution of Dr. Laverty has received research support from Dyne.
Rania A. Elenein, MD Dr. Elenein has nothing to disclose.
Nada G. Abou Fayssal, MD, FAAN Dr. Abou Fayssal has nothing to disclose.
Saad Abu Saleh No disclosure on file
Harirama K. Acharya, MD No disclosure on file
Katherine Agoropoulou, PhD No disclosure on file
Reto M. Agosti, MD No disclosure on file
Kamran A. Ahmed No disclosure on file
Franz Aichner, MD No disclosure on file
Angel Angelov, MD No disclosure on file
Tiara Aninditha, MD No disclosure on file
Tania Arguello No disclosure on file
Sourabh Arora No disclosure on file
Nazely Ashikian, MD Dr. Ashikian has nothing to disclose.
Hasan Askari, MD No disclosure on file
Edward Avila, DO, FAAN Dr. Avila has received publishing royalties from a publication relating to health care.
Tomislav Babic No disclosure on file
Olivier Bailon, MD No disclosure on file
Steven K. Baker, MD Dr. Baker has nothing to disclose.
Roumen D. Balabanov, MD Dr. Balabanov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Balabanov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Balabanov has received research support from NextCure. The institution of Dr. Balabanov has received research support from Biogen. The institution of Dr. Balabanov has received research support from NINDS.
Diana Balsalobre, MD No disclosure on file
Brendan Bauer, MD, FAAN No disclosure on file
William R. Bauer, MD, PhD, FAAN No disclosure on file
Taylor C. Bear, MD No disclosure on file
Steven Benedict, MD Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SKLife. The institution of Dr. Benedict has received research support from Sanofi. The institution of Dr. Benedict has received research support from Novartis.
Regina Berkovich, MD, PhD The institution of Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion, Biogen, Genentec, Mallincrodt, Sanofi, Novartis, . Dr. Berkovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Genentec, Sanofi, Merck . Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion, Biogen, Sanofi, Merck, Mallincrodt . The institution of Dr. Berkovich has received research support from Biogen, Sanofi, Merck.
Niklas Beyersdorf, MD No disclosure on file
Meetu Bhogal, MSc No disclosure on file
James Bicksel, MD No disclosure on file
Roberto Bomprezzi, MD, FAAN Dr. Bomprezzi has nothing to disclose.
Abdalla Bowirrat No disclosure on file
Esther Brusse No disclosure on file
Catherine Buettner, MD No disclosure on file
Regine Buffels, MD Dr. Buffels has nothing to disclose.
Adrian Burgos, MD No disclosure on file
Kate Busby, MD No disclosure on file
Susan Cadell, PhD No disclosure on file
Elisa Canu The institution of Elisa Canu has received research support from Italian Ministry of Health .
Doris Cardenas, MD No disclosure on file
Claudia Castiglioni, MD Dr. Castiglioni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Castiglioni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for PTC.
Barbara Changizi, MD Dr. Changizi has nothing to disclose.
Priya Chaudhary No disclosure on file
Xi Chen, MD, PhD No disclosure on file
Nancy Chiaravalloti The institution of Nancy Chiaravalloti has received research support from NIH. The institution of Nancy Chiaravalloti has received research support from NIDILRR.
Min Kyung Chu, MD, PhD No disclosure on file
Florence Chukwuneke, RN No disclosure on file
Jae-Myun Chung, MD No disclosure on file
Melissa M. Cortez, DO The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
Benjamin Cretin, MD No disclosure on file
Kathe Dahlbom, MD No disclosure on file
Maame Dankwah, MD No disclosure on file
Macarena De La Fuente, MD Dr. De La Fuente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. De La Fuente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pyramid Biosciences. An immediate family member of Dr. De La Fuente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. De La Fuente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ADC Therapeutics.
Joao M. De Moraes, MD, PhD No disclosure on file
John DeLuca, PhD, ABPP Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. DeLuca has received research support from Biogen.
Feza Deymeer, MD No disclosure on file
Kelly Donnelly, DO No disclosure on file
Doumos Loannis No disclosure on file
Hacer Durmus, MD Dr. Durmus has nothing to disclose.
Rima N. El-Abassi, MD Dr. El-Abassi has nothing to disclose.
Dante Facchetti No disclosure on file
Robert J. Fallis, MD No disclosure on file
Simona Ferioli, MD Dr. Ferioli has nothing to disclose.
Stephen D. Forner, MD No disclosure on file
Fiona Forrestal No disclosure on file
Stephen Gancher, MD, FAAN No disclosure on file
Marek Gawel, FRCPC No disclosure on file
Pahari Ghosh, MD, MBBS, MRCP No disclosure on file
Tania Giovannetti No disclosure on file
Donna C. Graves, MD, FAAN Dr. Graves has nothing to disclose.
Jennifer Graves, MD, PhD Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Michelle Greer No disclosure on file
Waldo Guerrero, MD Dr. Guerrero has nothing to disclose.
Vincenzo Guidetti No disclosure on file
Kymberly Gyure, MD No disclosure on file
Rachel Halpern, PhD No disclosure on file
Elizabeth A. Hartman, MD An immediate family member of Dr. Hartman has or had stock in Amgen.
Agust Hilmarsson, MD No disclosure on file
Andrew Ho No disclosure on file
Ulrich Hofstadt-van Oy, MD No disclosure on file
Dagny N. Holle, MD Dr. Holle has nothing to disclose.
Stephanie Hreha No disclosure on file
Jason Huse No disclosure on file
Shalaka D. Indulkar, MD No disclosure on file
Margaret E. Jaynes, MD Dr. Jaynes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus.
David T. Jones, MD Dr. Jones has stock in Cephlodyne Neurotechnologies, Inc.. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care.
Meena A. Kanikannan, MD No disclosure on file
Johanne M. Kaplan, PhD Dr. Kaplan has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Kaplan has stock in ProMIS Neurosciences. Dr. Kaplan has received intellectual property interests from a discovery or technology relating to health care.
Alexander-Thomas Kerkau, MD No disclosure on file
Sara Khan, MD Dr. Khan has nothing to disclose.
Jane Kim, MD No disclosure on file
Priya Kishnani, MD Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maze Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for JCR Pharmaceutical. Priya Kishnani, MD has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Asklepios Biopharmaceutical Inc. (AskBio). Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Baebies, Inc.. The institution of Priya Kishnani, MD has received research support from Sanofi/Genzyme. Priya Kishnani, MD has received research support from Amicus Therapeutics. Priya Kishnani, MD has received intellectual property interests from a discovery or technology relating to health care. Priya Kishnani, MD has received intellectual property interests from a discovery or technology relating to health care.
Aaron P. Kithcart No disclosure on file
Nina Kleiner, MD No disclosure on file
David Kline, MD No disclosure on file
Michael Ko, MD No disclosure on file
Carol L. Koski, MD No disclosure on file
Vassiliki Kotsi No disclosure on file
Wolfgang Kristoferitsch, MD No disclosure on file
Krista Kuitwaard, MD No disclosure on file
Christopher C. LaGanke, MD Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GSK. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Serono EMD. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics.
Jennifer A. Langsdorf, MD Dr. Langsdorf has nothing to disclose.
Connie Lau, MS, CCRC No disclosure on file
Dong Young Lee, MD, PhD No disclosure on file
David P. Libell, MD, FAAN No disclosure on file
Andrew L. Lin, MD The institution of Dr. Lin has received research support from Bristol Myers Squibb. The institution of Dr. Lin has received research support from NantOmics. The institution of Dr. Lin has received research support from Society of Memorial Sloan Kettering Cancer Center.
Xinrong Lu, MD, PhD No disclosure on file
Shalini Mahajan, MD, FAAN No disclosure on file
Wolfgang Mair, MD No disclosure on file
Charles Maitland No disclosure on file
Daniel A. Mandel, PhD No disclosure on file
Karen Marr, BA No disclosure on file
Martin Marziniak, PhD No disclosure on file
Paul G. Mathew, MD, DNBPAS, FAHS, FACSM, FAAN Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie/Allergan. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Mathew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven/Pfizer. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Dominick J. McCabe, MD, PhD No disclosure on file
Eva Medova No disclosure on file
Michelle L. Mellion, MD Dr. Mellion has received personal compensation for serving as an employee of PepGen. Dr. Mellion has stock in PepGen.
Tamara Miller, MD Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics Therapeutics, Abbvie, Genentech. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono, TG Therapeutics, Biogen, Abbvie, Genentech, Lundbeck. The institution of Dr. Miller has received research support from Abbvie, Ipsen, Alexion, Pfizer, BMS, Genentech, ThermoFisher Scientific.
Wazim Mohamed, MD Dr. Mohamed has nothing to disclose.
Sulaiman Mohammad, MD No disclosure on file
Nimish A. Mohile, MD, FAAN The institution of Dr. Mohile has received research support from Novocure.
Obinna I. Moneme, MD No disclosure on file
Najib I. Murr, MD, FAAN Dr. Murr has nothing to disclose.
Hiroyuki Nodera, MD No disclosure on file
Barbara Nuesslein-Hildesheim, PhD Dr. Nuesslein-Hildesheim has received personal compensation for serving as an employee of Novartis Pharma AG. Dr. Nuesslein-Hildesheim has stock in Novartis Pharma AG.
Kimberly H. Oas, RN, MSN No disclosure on file
Carly B. Oboudiyat, MD No disclosure on file
Elias Olafsson, MD, PhD No disclosure on file
Winston R. Ortiz, MD No disclosure on file
Spozhmy Panezai, MD Dr. Panezai has nothing to disclose.
Dimitrios Papadopoulos, MD No disclosure on file
Helen Papageorgiou, MD No disclosure on file
Juan C. Parra Riaza Juan C. Parra Riaza has received personal compensation for serving as an employee of AbbVie INC. Juan C. Parra Riaza has stock in AbbVie INC.
Allyson Parry No disclosure on file
Shivani C. Patel No disclosure on file
Vishal Patel, MD No disclosure on file
Otto Pedraza The institution of Otto Pedraza has received research support from Alzheimer's Association. Otto Pedraza has received publishing royalties from a publication relating to health care.
Elena Pentsova, MD The institution of Dr. Pentsova has received research support from YmAbs Therapeutics, Inc.
Chase Petersen No disclosure on file
Panayiota Petrou No disclosure on file
Mark W. Pierce, MD, PhD No disclosure on file
Piraye Serdaroglu, MD No disclosure on file
Ute Pohl, MD No disclosure on file
Suyash Prasad, MBBS Dr. Prasad has received personal compensation for serving as an employee of Audentes Therapeutics. Dr. Prasad has received stock or an ownership interest from Audentes.
Stephen M. Rao, PhD No disclosure on file
Helmut Rauschka, MD No disclosure on file
Jennifer L. Reardon Jennifer L. Reardon has received personal compensation for serving as an employee of Bristol Myers Squibb.
Bruce Roberts, PhD No disclosure on file
Eliana Rodillo, MD No disclosure on file
Marc Rosenblum No disclosure on file
Sarah Sahib No disclosure on file
Hassan H. Salama, MD, PhD No disclosure on file
Paulo Marcelo G. Sales No disclosure on file
Sonemany Salinthone, PhD Dr. Salinthone has nothing to disclose.
Adrienne Salomon, MD No disclosure on file
Olga Sanchez Solino, MD Dr. Sanchez Solino has received personal compensation for serving as an employee of AbbVie. Dr. Sanchez Solino has received stock or an ownership interest from AbbVie.
Marie-Laure Santiago-Raber, PhD No disclosure on file
Fumitaka Sato, PhD No disclosure on file
Bilal Saulat, MD No disclosure on file
Christopher A. Scheiner, MD, PhD Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Scheiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx Pharmaceuticals. Dr. Scheiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansssen. Dr. Scheiner has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for CSL Behring . Dr. Scheiner has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Scheiner has received research support from Alexion Pharmaceuticals .
Peter Schnabl, MD No disclosure on file
Claudio Semplicini No disclosure on file
Jennifer N. Serventi, PA Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
William M. Siders, PhD No disclosure on file
Jason Silversteen, DO Dr. Silversteen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Silversteen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Silversteen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche-Genentech.
Susan Simonyi, RN No disclosure on file
Kartik Sivaraaman, MD No disclosure on file
Paul A. Smith No disclosure on file
Negar Sodeifi, MD No disclosure on file
Seyed Ali Sonbolestan, MD No disclosure on file
Jose G. Speciali, MD No disclosure on file
James Stark, MD, FAAN Dr. Stark has nothing to disclose.
James F. Sumowski Mr. Sumowski has nothing to disclose.
Shahamat Tauhid, MD Dr. Tauhid has nothing to disclose.
Sean Taylor, MD No disclosure on file
Carlos A. Teixeira, MD No disclosure on file
Cory Teuscher, PhD No disclosure on file
April H. Thompson No disclosure on file
Dinah Thyerlei, MD, FAAN No disclosure on file
Robert Tiel, MD No disclosure on file
Jan-Mendelt Tillema, MD Dr. Tillema has nothing to disclose.
Sofia Tsiara, MD No disclosure on file
Ikuo Tsunoda, PhD No disclosure on file
Michael J. Turner, PhD No disclosure on file
Dimitrios Tzortzis No disclosure on file
Jean-Sebastien Vidal No disclosure on file
Mary Walch No disclosure on file
Ryan D. Walsh, MD No disclosure on file
Huijun Wang, MD, PhD No disclosure on file
Joreg R. Weber No disclosure on file
Theodore Wein, MD No disclosure on file
Martin Weygandt, PhD No disclosure on file
Crystal G. Wheeler No disclosure on file
Chad Whyte, MD No disclosure on file
Armistead Williams III, MD Dr. Williams has nothing to disclose.
Leslie B. Williams, MD No disclosure on file
Anke C. Winter, MD, MSc No disclosure on file
Douglas A. Wright, MD No disclosure on file
Tresa Zacharias, MD An immediate family member of Dr. Zacharias has received personal compensation for serving as an employee of HCSC. Dr. Zacharias has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Liberty Mutual. Dr. Zacharias has received publishing royalties from a publication relating to health care.
Muhammad Zaidi, MD Dr. Zaidi has nothing to disclose.
Sebastian Zaremba, MD No disclosure on file
Lixin Zhang-Auberson, MD, PhD No disclosure on file
Julian Zimmermann No disclosure on file
William Rooney, PhD Dr. Rooney has nothing to disclose.
Toby I. Gropen, MD Dr. Gropen has nothing to disclose.
Kerri S. Remmel, MD, PhD Dr. Remmel has nothing to disclose.
Lutz Harms No disclosure on file
Wiley Hall, MD No disclosure on file
Amy K. Guzik, MD, FAAN Dr. Guzik has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Local law firms, available by request.
Pablo B. Winckler, MD, PhD Dr. Winckler has nothing to disclose.
Channa Kolb, MD No disclosure on file
Marilyn Matthew No disclosure on file
Andrew Bursaw, DO No disclosure on file
Conrad Liang, MD Dr. Liang has nothing to disclose.
Hakan Akgun No disclosure on file
Kristen Dams-O'Connor, PhD Dr. Dams-O'Connor has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Dams-O'Connor has received research support from NIH. The institution of Dr. Dams-O'Connor has received research support from Department of Defense. The institution of Dr. Dams-O'Connor has received research support from National Institute on Disability Independent Living and Rehabilitation Research. The institution of Dr. Dams-O'Connor has received research support from Patient Reported Outcomes Research Institute.
Mary Carter Denny, MD Dr. Denny has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott Laboratory. The institution of Dr. Denny has received research support from NIDDILIR. Dr. Denny has received publishing royalties from a publication relating to health care.
Rachel P. Guimaraes, PT Ms. Guimaraes has nothing to disclose.
Luiza G. Piovesana, MD No disclosure on file
Lidia Sarro, MD No disclosure on file
Mehmet Yucel, MD No disclosure on file
M. M. Paz Soldan, MD, PhD Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Carl A. Gold, MD, FAAN Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a CME Course Presenter with Oakstone.
Keith Van Haren, MD Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viking Therapeutics. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebirdbio. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orpheris. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME, Inc. The institution of Dr. Van Haren has received research support from Minoryx. The institution of Dr. Van Haren has received research support from bluebirdbio. Dr. Van Haren has a non-compensated relationship as a Board of Directors with ALD Connect that is relevant to AAN interests or activities. Dr. Van Haren has a non-compensated relationship as a Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities.
Alexandra Dimitrova, MD Dr. Dimitrova has nothing to disclose.
Richard P. Goddeau, Jr., DO No disclosure on file
Lee S. Chung, MD Dr. Chung has nothing to disclose.
Phillip D. Swanson, MD No disclosure on file
Sudhir V. Datar, MD Dr. Datar has nothing to disclose.
Zurab Nadareishvili, MD, PhD No disclosure on file
Vishal Jani, MD Dr. Jani has nothing to disclose.
Malgorzata Wiszniewska No disclosure on file
Christa Watson No disclosure on file
Elisabeth G. Kramer, MD No disclosure on file
Joseph Duffy The institution of Joseph Duffy has received research support from NIH. Joseph Duffy has received publishing royalties from a publication relating to health care.
Richard D. Dortch, PhD Dr. Dortch has nothing to disclose.
Hyun J. Cho, MD Dr. Cho has nothing to disclose.
Martin D. Ollenschleger, MD No disclosure on file
Alexandra C. Boske, MD Dr. Boske has nothing to disclose.
Shnehal Patel, MD Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine.
Brenton A. Wright, MD Dr. Wright has nothing to disclose.
Cinthi Pillai, MD Dr. Pillai has nothing to disclose.
Siddhart K. Mehta, MD Dr. Mehta has nothing to disclose.
Christopher Olm No disclosure on file
Kimberly D. Johnson, MD No disclosure on file
Drini Dobi, MD, PhD No disclosure on file
Ajay M. Tunguturi, MD Dr. Tunguturi has nothing to disclose.
Gowri Lakshminarayan, MD No disclosure on file
Jay Pathmanathan, MD, PhD No disclosure on file
Kyung-Wha Kim, MD No disclosure on file
Hokuto Morita, MD No disclosure on file
Mohammed A. Hussain, MD No disclosure on file
Haris Kamal, MD Dr. Kamal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention .
Nora Vanegas-Arroyave, MD The institution of Dr. Vanegas-Arroyave has received research support from National Institutes of Health. The institution of Dr. Vanegas-Arroyave has received research support from MJFF.
Priyanka Sabharwal, MD, MBBS, FAAN Dr. Sabharwal has nothing to disclose.
Jonathan D. Victor, MD, PhD No disclosure on file
Fermina A. Pirmohamed, MD No disclosure on file
Trung P. Nguyen, MD The institution of Dr. Nguyen has received research support from National Institute on Aging. The institution of Dr. Nguyen has received research support from Texas Alzheimer's Research and Care Consortium. The institution of Dr. Nguyen has received research support from Biogen.
Jennifer Waldron, DO Dr. Waldron has nothing to disclose.
Anna Mrelashvili, MD No disclosure on file
Munro Cullum, PhD The institution of Dr. Cullum has received research support from NIH. Dr. Cullum has received intellectual property interests from a discovery or technology relating to health care. Dr. Cullum has received personal compensation in the range of $10,000-$49,999 for serving as a Scientific Director with Texas Alzheimers Research and Care Consortium.
Juliana Calvet Kallenbach Aurencao No disclosure on file
Ahmed A. Malik, MD No disclosure on file
Alvino Bisecco Alvino Bisecco has nothing to disclose.
Laura F. Santoso No disclosure on file
Michelle Rainka, PharmD Dr. Rainka has stock in Abbvie. Dr. Rainka has stock in acadia. Dr. Rainka has stock in alon. Dr. Rainka has stock in biogen. Dr. Rainka has stock in bristol myers squib. Dr. Rainka has stock in eisai. Dr. Rainka has stock in Lilly. Dr. Rainka has stock in novartis. Dr. Rainka has stock in pfizer. Dr. Rainka has stock in roche. Dr. Rainka has stock in Sage. Dr. Rainka has stock in alkermes.
Pamela Delgado No disclosure on file
Richard L. Yates No disclosure on file
Nagbhushan S. Rao, MD, FAAN No disclosure on file
David M. Burke, MD No disclosure on file
Claudia J. Chaves, MD, FAAN No disclosure on file
Jennifer R. Friedman, MD An immediate family member of Dr. Friedman has received personal compensation in the range of $0-$499 for serving as a Consultant for Sinopia Biosciences. An immediate family member of Dr. Friedman has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Pet Dx. Dr. Friedman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Friedman has stock in Friedman Bioventure .
Cathy Chuang, MD No disclosure on file
Carolyn Schwartz, ScD No disclosure on file
Robert Cantu, MD Dr. Cantu has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple law firms .
Ryan Coates, MD No disclosure on file
Victor Wang, MD, FAAN Dr. Wang has nothing to disclose.
Guannan Ge, MD No disclosure on file
Hannah Homafar, MD No disclosure on file
Chih-Wei Tang, MD No disclosure on file
Abdullah Tawakul, MD No disclosure on file
Joel H. Torres, MD No disclosure on file
Vijay A. Vishwanath, MD, PhD No disclosure on file
Sami Saba, MD Dr. Saba has nothing to disclose.
Peggy Nguyen, MD Dr. Nguyen has nothing to disclose.
Lidia Maria V. Moura, MD, PhD, MPH, FAAN Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Moura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America . The institution of Dr. Moura has received research support from NIH - NIA and NINDS. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Expert Advisor with Epilepsy Foundation .
Quang D. Vu, MD No disclosure on file
Kanika Arora, MD No disclosure on file
Jorge G. Ortiz-Garcia, MD, FAAN Dr. Ortiz-Garcia has nothing to disclose.
Rajsekar R. Rajaraman, MD Dr. Rajaraman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Marinus Pharmacueticals.
Onjin Kim, MD No disclosure on file
Dasha Kenlan No disclosure on file
Mary E. Richert No disclosure on file
Robin L. Avila, PhD Mrs. Avila has received personal compensation for serving as an employee of Biogen. Mrs. Avila has stock in Biogen.
Renxin Chu Dr. Chu has nothing to disclose.
Huimahn A. Choi, MD The institution of Dr. Choi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti Pharma.
Rachel Salzman, DVM No disclosure on file
Athari K. Salmeen, MD No disclosure on file
Elizabeth R. DeGrush, DO Dr. DeGrush has nothing to disclose.
Victor Calil da Silveira, MD No disclosure on file
Lisena Hasanaj Ms. Hasanaj has nothing to disclose.
Patricia L. Henegan No disclosure on file
Dino Maglic No disclosure on file
Seyed Aidin Sajedi No disclosure on file
Marta Simone Marta Simone, 11772 has nothing to disclose.
Kevin Messacar, MD No disclosure on file
Andrew Welleford, MD, PhD Dr. Welleford has nothing to disclose.
Anuschka Grobelny No disclosure on file
Erika Silverman Ms. Silverman has nothing to disclose.
Francisco Sales, MD No disclosure on file
Dimitrios I. Zafeiriou, MD, PhD No disclosure on file
Krisztina Harsanyi, MD No disclosure on file
Jussara M. Khouri, MD Dr. Khouri has nothing to disclose.
David H. Dennison, MD, FAAN No disclosure on file
Michal Vytopil, MD Dr. Vytopil has nothing to disclose.
Meghan Candee, MD Dr. Candee has nothing to disclose.
Wamda Ahmed, MD No disclosure on file
Breyanna N. Grays, MD No disclosure on file
Jon Williams, DO, PhD Dr. Williams has nothing to disclose.
Peter Z. Yan, MD, MS Dr. Yan has nothing to disclose.
Junaid H. Siddiqui, MD Dr. Siddiqui has nothing to disclose.
Jaskiran Brar, MD No disclosure on file
Olivier Stevens, MD No disclosure on file
Harina K. Chahal, MD No disclosure on file
Kiran M. Kanth, MD Dr. Kanth has nothing to disclose.
Proleta Datta, MD Dr. Datta has nothing to disclose.
Assad F. Amin, MD No disclosure on file
Charenya Anandan, MD Dr. Anandan has nothing to disclose.
Christina M. Dheel No disclosure on file
Handan Ozisik Karaman No disclosure on file
Karina L. Pires, MD Dr. Pires has nothing to disclose.
Jefferson Becker, MD, PhD Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ASTRAZENECA. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ROCHE. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AMGEN. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MERCK. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ASTRAZENRCA. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMS.
Swathi Kondapalli, MD Dr. Kondapalli has nothing to disclose.
Yu-Ting Chen, MD Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
Rejo Cherian, MD Dr. Cherian has nothing to disclose.
Manmeet Kaur, MBBS Dr. Kaur has nothing to disclose.
Abhishek Lunagariya, MD No disclosure on file
Philip Chang, MD No disclosure on file
Alaa F. Khayat, MBBS No disclosure on file
Aliza B. Ben-Zacharia, PhD, PhD, DNP, ANP, FAAN Ms. Ben-Zacharia has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Theraputics. The institution of Ms. Ben-Zacharia has received research support from Biogen. The institution of Ms. Ben-Zacharia has received research support from Greenwich Biosciences.
Keren Regev, MD Dr. Regev has nothing to disclose.
Francis Odiase, MBBS No disclosure on file
Thomas Finnegan, Jr., PhD Dr. Finnegan has nothing to disclose.
Ihtesham Qureshi, MD No disclosure on file
John Mariani No disclosure on file
Daniel Korya, MD No disclosure on file
Noushin Jazebi, MD Dr. Jazebi has nothing to disclose.
Daniel S. Vitantonio, MD No disclosure on file
AmirHussein Abdolalizadeh No disclosure on file
Fawad Yousuf, MBBS Dr. Yousuf has nothing to disclose.
Kevin N. Ramdas, MD No disclosure on file
Luis Guada-Delgado, MD Dr. Guada-Delgado has nothing to disclose.
Meryem Tuba Goksungur No disclosure on file